netFormulary
 Report : A-Z of formulary items 17/06/2021 21:07:27
[Back]
 
Section Name Details
14.04 23-valent pneumococcal polysaccharide vaccine Previously known as Pneumovax® II

order via IMMFORM WEBSITE

PGD - see chapter link above

 

10.01.03 Abatacept 
This drug is NHSE funded for the indication outlined within the Ex-Tariff list.
Must complete Blueteq
Suitable for shared care between Specialist and Secondary Care via network model. 
 
02.09 Abciximab 
08.01.05 Abemaciclib Verzenios ®

This drug is NHSE funded for the indications outlined within the Ex-Tariff List (Blueteq Drug) 

This drug is funded by the CDF for the indication outlined within the CDF list (Blueteq Drug)

08.03.04.02 Abiraterone Zytiga®

This drug is NHSE funded for the indication outlined withIn the Ex-Tariff list.

Must complete Blueteq

Suitable for shared care between Specialist and Secondary Care via network model. 

03.01.05 Able Spacer® 
08.01.05 Acalabrutinib 

This drug is funded by the CDF for the indication outlined within the CDF list (Blueteq Drug)

04.10.01 Acamprosate 
02.08.02 Acenocoumarol 
04.08.01 Acetazolamide 
11.06.03.01 Acetazolamide (oral) 
12.01.01 Acetic Acid 2% Earcalm ®

Can be purchased OTC from 12 years

05.03.02.01 Aciclovir 
11.03.03 Aciclovir eye ointment 3% 
01.01.02 Acidex 

Self Care Self Care Medicine: Heartburn/Indigestion from 6 yrs

13.05.02 Acitretin 
03.01.02 Aclidinium Eklira Genuair®

NB: Not currently supported by the COPD pathway

03.01.04 Aclidinium and formoterol inhaler 
19.06 Actico 2c  Leg Ulcer Kit

Use

Compression therapy for venous ulcers, with or without uncomplicated chronic oedema. Suitable for mobile and immobile patients. A two component latex free leg ulcer kit. Comfort layer 1 with foam padding and compression layer 2 inelastic cohesive compression layer.

Application

Always measure above the malleoli at each application. Doppler assessment required prior to the application of compression therapy.

Tips

Latex free.
Apply as manufacturer’s instructions.
May be left in place for 7 days.
Ensure 50% overlap exact and no 'windows' or the pressure will be uneven.
Always bandage foot and ankle with 'toes to nose'.

Avoid

Any form of compression bandaging should not be undertaken without prior education and competency assessment.
Not suitable for anybody with an ankle circumference of <18cm.
Arterial disease, arterial ulcers, diabetes and those with small vessel disease, leg swelling.

 

19.06 Actico Cohesive Bandage compression bandage - short stretch

Use

Venous leg ulceration and lymphoedema.
For use with those that are mobile/limited mobility, i.e. able to walk to the toilet independently.

Application

Applied at full stretch using spiral bandage method as per manufacturer’s instructions.
Doppler assessment required prior to the application of compression therapy.

Tips

Apply as manufacturer’s instructions.
May be left in place for 7 days.
For oedema/lymphoedema management a 4 cm x 6 m and a 6 cm x 6 m are available.

Avoid

Any form of compression bandaging should not be undertaken without prior education and competency assessment.
Arterial disease, arterial ulcers, diabetes and those with small vessel disease.

 

19.23 Acti-Fast 

Elasticated cotton tubular retention bangade

19.13 Actiform Cool 

Use

Primarily for wounds that are painful.
To rehydrate necrotic/sloughy wounds and to manage moderately exuding wounds that also require slough removal.

Application

Apply directly to the wound bed.
Can be cut to the shape of wound.
For low exuding wounds leave the second backing film in place.
For moderately exuding wounds both backing films should be removed and a secondary absorbent dressing applied over.
May be left in place for up to 7 days in low exuding wounds.
Will require a secondary dressing.

Tips

Dressing absorbs wound slough into its matrix forming a globular gel - this may help to reduce the microbial burden of the wound bed.
Protect the surrounding skin with a barrier film/cream in moderately exuding wounds.
Seek advice from a wound specialist before use on diabetic patients.

Avoid

Do not use on clinically infected wounds unless the patient is on systemic antibiotic therapy.
Avoid secondary dressing with cellulose granules.

 

19.17 Activated charcoal dressing Clinisorb
19.11 Activon Tube Medical grade manuka honey

Use

Suitable for use in cavity wounds. Sloughy, infected and/or malodorous wound.
Osmotic action for desloughing and debriding wounds.
Has an antimicrobial property.

Application

Apply directly to wound bed or cavity.
Secondary dressing required.

Tips

Pre warm prior to application.
Has osmotic action, fluid will be drawn from the wound; this can increase pain level initially. Can be washed out with saline.
Change dressing when honey is diluted by exudate. Monitor blood glucose levels of those with diabetes.

Avoid

If allergic to bee venom.

 

19.11 Activon Tulle Impregnated with manuka honey

Use

Sloughy and/or malodorous wound.
Osmotic action for desloughing and debriding wounds.
Has an antimicrobial property.

Application

Apply directly to wound bed.
Secondary dressing required.

Tips

Pre warm prior to application.
Has osmotic action, fluid will be drawn from the wound; this can increase pain level initially.
Change dressing when honey is diluted by exudate. Monitor blood glucose levels of those with diabetes.

Avoid

If allergic to bee venom.

 

06.01.01.01 Actrapid® 
01.05.03 Adalimumab 
This drug is NHSE funded for the indication outlined within the Ex-Tariff list.
NHSE commissioned for Paediatric Indications (where Adult TA available)
Specialist Centre Only
Blueteq to be completed
Biosimilar available: If more than one treatment is suitable, the most cost-effective option should be selected.
 
CCG funded as per NICE TAGs below
10.01.03 Adalimumab 
This drug is NHSE funded for the indication outlined within the Ex-Tariff list.
NHSE Commissioned for Juvenile Arthritis - Paediatric
Must complete Blueteq
Suitable for shared care between Specialist and Secondary Care via network model.
 
NHSE commissioned for Paediatric Indications (where Adult TA available)
Specialist centre Only
 
Not routinely commssioned for non bacterial osteomyelitis/ostetitis.  IFR required.  
 
13.05.03 Adalimumab 
This drug is NHSE funded for the indication outlined within the Ex-Tariff list.
SaTH is not a specialist centre for Hidradenitis Suppurativa.
 
NHSE commissioned for Paediatric Indications (where Adult TA available)
Specialist centre Only
 
Black Triangle: Hyrimoz and Amgevita
09.03 Addiphos® 
09.03 Additrace® 
02.03.02 Adenosine 
02.07.02 Adrenaline / epinephrine 
03.04.03 Adrenaline / epinephrine pre-filled pen
03.04.03 Adrenaline / epinephrine 1 in 1,000 
02.07.03 Adrenaline / Epinephrine 1 in 10,000  
03.01.05 AeroChamber Plus ® 
08.01.05 Afatinib Giotrif®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

Suitable for shared care between Specialist and Secondary Care via network model.

11.08.02 Aflibercept 
09.08.01 Agalsidase Alfa and Beta Fabrazyme®

SaTH is not a specialist centre

This drug is NHSE funded for the indication outlined withn the Ex-Tariff list.

SPECIALIST CENTRE ONLY.

09.08.01 Agalsidase Alfa and Beta Replagal®

SaTH is not a specialist centre

This drug is NHSE funded for the indication outlined withn the Ex-Tariff list.

SPECIALIST CENTRE ONLY.

09.02.02.02 Albumin 

Hospital supply = Pathlab

08.01.05 Alectinib Alecensa®

This drug is NHSE funded for the indications outlined within the Ex-Tariff List (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model.

08.02.03 Alemtuzumab Lemtrada®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq Drug)

08.02.03 Alemtuzumab MabCampath®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq Drug)

Suitable for shared care between Specialist and Secondary Care via network model. 

06.06.02 Alendronic Acid once weekly

For Osteoporosis

09.06.04 Alfacalcidol One-Alpha®
15.01.04.03 Alfentanil 
07.04.01 Alfuzosin 
09.08.01 Alglucosidase Alfa Myozyme®

SPECIALIST CENTRE ONLY

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

02.12 Alirocumab 
13.05.01 Alitretinoin 
10.01.04 Allopurinol 
06.01.02.03 Alogliptin 
09.06.05 Alpha Tocopheryl Acetate 
07.04.05 Alprostadil Caverject®
07.04.05 Alprostadil Viridal® Duo
07.04.05 Alprostadil MUSE®

CCG policy limits treatment to 4 urethral sticks per month

02.10.02 Alteplase 
09.05.02.02 Aluminium Hydroxide Alu-Cap®

To be prescribed for existing patients only

04.09.01 Amantadine 
05.01.04 Amikacin 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list ONLY if an IFR is completed and approved.

SPECIALIST CENTRE ONLY

11.03.01 Amikacin 
02.02.03 Amiloride Hydrochloride 
03.01.03 Aminophylline 
03.01.03 Aminophylline IV 
02.03.02 Amiodarone 

Amiodarone must not be initiated in primary care. It must be initiated by a specialist and only continued under a shared care arrangement for patients where other treatments cannot be used, have failed or is in line with NICE Guidance CG180. It may also be suitable in patients prior and post cardioversion or in specific patients who also have heart failure or left ventricular impairment.

Amiodarone has an important place in the treatment of severe cardiac rhythm disorders where other treatments either cannot be used or have failed. It has potential major toxicity and its use requires monitoring both clinically and via laboratory testing.

NICE clinical guideline on Atrial Fibrillation (AF) CG 180 puts greater emphasis on rate rather than rhythm control and has clarified the place of amiodarone in the treatment pathway

NICE have issued the following “Do not do” recommendation:

Do not offer amiodarone for long-term rate control.  

04.02.01 Amisulpride 
04.03.01 Amitriptyline 
04.07.03 Amitriptyline 
04.07.04.02 Amitriptyline 
02.06.02 Amlodipine 
05.01.01.03 Amoxicillin 
05.02 Amphotericin Fungizone®

** Must be prescribed by BRAND' **

05.02 Amphotericin AmBisome®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

Suitable for shared care between Specialist and Secondary Care via network model

** Must be prescribed by BRAND' **

09.01.04 Anagrelide 
10.01.03 Anakinra 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list. Some indications require an IFR to be completed and approved. Also confirm SaTH is a SPECIALIST CENTRE for the indication stated.

Blueteq form required (Blueteq Drug).
Suitable for shared care between Specialist and Secondary Care via network model.
 
 
08.03.04.01 Anastrozole 
02.08.02 Andexanet Alpha  Ondexxya®

To be used in MAU on advice from on call heamatologist

05.02.04 Anidulafungin Ecalta®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

Suitable for shared care between Specialist and Secondary care via network model.

14.04 Anthrax vaccine 
06.01.01.01 Apidra® 
02.08.02 Apixaban 
04.09.01 Apomorphine 

This medication requires an ESCA

11.08.02 Apraclonidine Iopidine®
10.01.03 Apremilast rheumatology
13.05.03 Apremilast Dermatology
04.06 Aprepitant 
A2.03.01 Aptamil Pepti-Junior 
19.04 Aquacel Ag Foam ADHESIVE 

MUST be prescribed as a course of treatment
MUST be reviewed every 2-weeks
Ongoing treatment after 2-weeks MUST be discussed with a specialist

For step down from Aquacel Foam with Aquacel Ag+ Extra underneath

8cm x 8cm
10cm x 10cm
12.5cm x 12.5cm
17.5cm x 17.5cm
19.8cm x 14cm (Heel)
20cm x 16.9cm (Sacral)

19.04 Aquacel Ag Foam NON-ADHESIVE 

MUST be prescribed as a course of treatment
MUST be reviewed every 2-weeks
Ongoing treatment after 2-weeks MUST be discussed with a specialist

For step down from Aquacel Foam with Aquacel Ag+ Extra underneath

5cm x 5cm
10cm x 10cm
15cm x 15cm

19.04 Aquacel Ag+ Extra 
 

MUST be prescribed as a course of treatment
MUST be reviewed every 2-weeks
Ongoing treatment after 2-weeks MUST be discussed with a specialist

Use

For infected and critically colonised wounds.
Moderate to heavy exuding wounds.
Must be prescribed as a course of treatment.
Must be reviewed every two weeks.
Ongoing treatment after two weeks must be discussed with a specialist.

Application

Apply directly onto wound bed, overlapping the surrounding skin by 2 cm. Requires a secondary dressing.

Tips

May be applied pre-moistened with saline for dry wounds.
Change when saturated with exudate - maximum 7 days.

Avoid

Sensitivity to silver and sulphonamides.

 

19.04 Aquacel Ag+ Ribbon 
 

MUST be prescribed as a course of treatment
MUST be reviewed every 2-weeks
Ongoing treatment after 2-weeks MUST be discussed with a specialist

Use

For infected and critically colonised wounds.
Moderate to heavy exuding wounds.
Must be prescribed as a course of treatment.
Must be reviewed every two weeks.
Ongoing treatment after two weeks must be discussed with a specialist.

Application

Apply directly into cavity wound, overlapping excess if required. Requires a secondary dressing.

Tips

May be applied pre-moistened with saline for dry wounds.
Change when saturated with exudate - maximum 7 days.

Avoid

Sensitivity to silver and sulphonamides.

 

19.18 Aquacel Extra 

 

Use

Moderate to heavy exuding wounds.
May be used on clinically infected wounds.
Is recognised to be a protease modulating dressing

Application

Apply directly onto wound, overlapping the surrounding skin by 2 cm.
Requires a secondary dressing.

Tips

Can be left for a maximum of 7 days, however needs to be changed when fully saturated.

Avoid

Do not use on dry wounds.
DO NOT USE IN CONJUNCTION WITH HYDROGELS

 

19.10 Aquacel Foam Adhesive 

 

Use

Management of acute and chronic exuding wounds – leg ulcers, pressure ulcers (II to IV), diabetic ulcers, post-op surgical wounds, partial thickness burns, traumatic wounds, exudate absorption in oncology wounds (fungating cutaneous tumours, cutaneous metastases and Kaposi’s sarcomas). May be used as a primary or secondary dressing and can be cut to shape and size. If the adhesive dressing is cut, additional tape may be required to secure it in place.

Application

Before applying the dressing cleanse the wound area with an appropriate wound cleanser and dry the surrounding skin. Choose a dressing size and shape to ensure that the central absorbent pad (area within the adhesive window) is 1 cm larger than the wound area. Change when clinically indicated, maximum recommended wear time is up to 7 days.

Tips

Use Aquacel foam dressing with Aquacel Extra dressing to provide extra absorbency on wounds with heavy exudate. Non adhesive range is available if required.

Avoid

Use with hydrogel.

 

19.10 Aquacel Foam Non-Adhesive 

For patients with silicone sensitivity or for use under compression

19.18 Aquacel Ribbon 

Use

Moderate to heavy exuding cavity wounds.
Can be left for a maximum of 7 days, however needs to be changed when fully saturated.

Application

Apply directly onto wound or cavity, overlapping the excess if required. Requires a secondary dressing.

Tips

Not suitable for infected wounds

Avoid

Do not use on dry wounds.
DO NOT USE IN CONJUNCTION WITH HYDROGELS

 

13.02.01 Aquamax ®Cream 

Self Care Self Care Medicine: Contact dermatitis/atopic eczema/dry skin in adults and children

01.06.03 Arachis Oil 
02.08.01 Argatroban 
04.02.01 Aripiprazole 
04.02.02 Aripiprazole prolonged-release suspension for injection
04.02.03 Aripiprazole mania and hypomania
08.01.05 Arsenic Trioxide Trisenox®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug).

Suitable for shared care between specialist and secondary care via network model.

15.02 Articaine Hydrochloride with Adrenaline 
12.03.05 Artificial saliva 
04.07.01 Aspirin dispersible
02.09 Aspirin (antiplatelet) 
10.02 Ataluren 
10.04 Ataluren 
02.04 Atenolol 
08.01.05 Atezolizumab Tecentriq®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq Drug)

This drug is funded by the CDF for the indication outlined within the CDF list (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model.

04.04 Atomoxetine 
02.12 Atorvastatin 

80mg DAILY - Secondary prevention

20mg DAILY - Primary prevention

07.01.03 Atosiban 
05.04.08 Atovaquone pneumocystis pneumonia
15.01.05 Atracurium Besilate 
19.24 Atrauman 
11.05 Atropine 

Only for patients unable to use the single use product

15.01.03 Atropine  
18 Atropine 
11.05 Atropine Sulphate single use 
09.01.04 Avatrombopag 
08.01.05 Avelumab Bavencio

This drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug).

This drug is funded by the CDF for the indication outlined within the CDF list (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model.

08.01.05 Axitinib Inlyta®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug).

Suitable for shared care between specialist and secondary care via network model.

A2.02.01.02 AYMES Shake 

Savoury option only

08.01.03 Azacitidine Vidaza®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

 

Suitable for shared care between specialist and secondary care via network model.

01.05.03 Azathioprine 
08.02.01 Azathioprine 

This drug is NHSE funded for the indications within the Ex-Tariff list.

Amber  Amber for most indications

red Immunosuppression for transplant patients which is an NHS funded indication

10.01.03 Azathioprine 
13.05.03 Azathioprine 
05.01.05 Azithromycin 
05.01.02.03 Aztreonam Azactam®
05.01.02.03 Aztreonam nebuliser solution Cayston®
09.03 Babiven start up 
10.02.02 Baclofen 
11.08.01 Balanced Salt Solution 

Only for theatre

01.05 Balsalazide 

Brand as indicated by specialist

10.01.03 Baricitinib 
13.05.03 Baricitinib Olumiant®
08.02.02 Basiliximab Simulect®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list.

08.02.04 BCG bladder instillation OncoTICE®
08.02.04 BCG bladder instillation ImmuCyst®
14.04 BCG vaccine diagnostic agent 

Order via IMMFORM WEBSITE 

20 units per ml - Mantoux test
100 units per ml - Mantoux test (if first test is negative and a further test is considered appropriate)

03.02 Beclometasone Qvar®
03.02 Beclometasone and formoterol Fostair NEXThaler®
03.02 Beclometasone and formoterol Fostair®
03.02 Beclometasone Dipropionate Clenil Modulite®
12.02.01 Beclometasone Dipropionate 

Self Care Self Care Medicine: Seasonal allergic rhinitis (hayfever) from 18 years

10.01 Belimumab 
02.12 Bempedoic acid nilemdo®

SaTH only
Dr Capps only

02.12 Bempedoic acid with Ezetmibe Nustendi®

Started on patients who are statin intolerant

08.01.01 Bendamustine 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

This drug is funded by the CDF for the indications outlined within the CDF list (Blueteq Drug).

Suitable for shared care between specialist and secondary care via network model.

02.02.01 Bendroflumethiazide 
15.02 Benzocaine 20% Gel 
12.03.01 Benzydamine Mouth wash and throat spray

Self Care Self Care Medicine: Thoat spray for sore throats in adults and children

05.01.01.01 Benzylpenicillin 
11.03.01 Benzylpenicillin  

Restricted for ophthalmic use via discussion with microbiology and ophthalmology

04.06 Betahistine Dihydrochloride 
06.03.02 Betamethasone Betnesol®
10.01.02 Betamethasone 
12.01.01 Betamethasone  
12.02.01 Betamethasone  
12.03.01 Betamethasone 
13.04 Betamethasone (as Dipropionate) 0.05% with Salicylic Acid 3% Diprosalic®
13.04 Betamethasone (as Valerate) 0.025% Betnovate-RD®
13.04 Betamethasone (as Valerate) 0.1% Betnovate®
12.01.01 Betamethasone 0.1% with Neomycin 0.5% ear drops 
11.04.01 Betamethasone 0.1% with Neomycin 0.5% eye drops 
11.04.01 Betamethasone eye drops 
11.04.01 Betamethasone eye ointment 
12.02.03 Betamethasone Sodium Phosphate 0.1% with Neomycin Sulphate 0.5% 
11.06.02.01 Betaxolol 
11.06.02.02 Betaxolol preservative free Betoptic®

Preservative free products are an option if the patient:
1. Has a preservative allergy 
2. Has significant external eye disease
3. Wears soft contact lenses

08.01.05 Bevacizumab Avastin®

This drug is funded by the CDF for the indications outlined within the CDF list.

Suitable for shared care between specialist and secondary care via network model.

11.08.02 Bevacizumab intravitreal injection 

Individual Funding Request only. 

Apply for funding through appropriate CCG.

02.12 Bezafibrate 
08.03.04.02 Bicalutamide 
11.06.01.01 Bimatoprost 

Default 100mcg/ml strength to be prescribed

11.06.01.04 Bimatoprost 0.3mg/ml with timolol 5mg/ml preservative free Ganfort® preservative free

Preservative free products are an option if the patient:
1. Has a preservative allergy 
2. Has significant external eye disease
3. Wears soft contact lenses

11.06.03.04 Bimatoprost 0.3mg/ml with Timolol 5mg/ml preservative free Ganfort®

Preservative free products are an option if the patient:
1. Has a preservative allergy 
2. Has significant external eye disease
3. Wears soft contact lenses

11.06.01.02 Bimatoprost preservative free Lumigan®

First line choice on the preservative free pathway.

Preservative free products are an option if the patient:
1. Has a preservative allergy 
2. Has significant external eye disease
3. Wears soft contact lenses

11.06.01.03 Bimatoprost with Timolol Ganfort®
08.01.05 Binimetinib Mektovi®

This drug is NHSE funded for the indications outlined within the Ex-Tariff List (Blueteq Drug)

 

09.08.01 Biotin 

This drug is NHSE funded for the indication outlined in the Ex-tariff list at specialist centres only (SaTH is NOT a specialist centre)

01.06.02 Bisacodyl 

Self Care Self Care Medicine: Recommended for use only in people aged 18 years or older. Should no longer be used in children under 12 years without advice from a prescriber, while products for children aged 12 to 17 years can be supplied under the supervision of a pharmacist.

 

02.04 Bisoprolol 
08.01.02 Bleomycin 

NHSE funded through routine commissioning for chemotherapy regimes

08.02 Blinatumomab Blincyto®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list

12.03.01 Bonjela teething gel 

Self Care Self Care Medicine: Teething from 2 months

14.04 Boostrix-IPV 

order via IMMFORM WEBSITE

PGD - see chapter link above

 

08.01.05 Bortezomib Velcade®

This drug is funded by the CDF for the indications outlined within the CDF list.

Suitable for shared care between specialist and secondary care via network model.

02.05.01 Bosentan 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

08.01.05 Bosutinib Bosulif®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug).

Suitable for shared care between specialist and secondary care via network model.

04.09.03 Botulinum Toxin Type A Dysport®
04.09.03 Botulinum Toxin Type A Botox®
11.99.99.99 Botulinum Toxin Type A 

Restricted to the following indications:
Blepharospasm
Squint
Inducing ptosis

04.09.03 Botulinum Toxin Type B NeuroBloc®
14.04 Botulism antitoxin 

Treatment of botulism from Clostridium botulinum types A, B and E in the acute setting only

18 Botulism antitoxin antidote
08.01.05 Brentuximab vedotin Adcetris®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model.

08.01.05 Brigatinib Alunbrig

This drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug).

Suitable for shared care between specialist and secondary care via network model.

11.06.04.01 Brimonidine Tartrate 
11.06.04.02 Brimonidine Tartrate 0.2% with Timolol 0.5% 
11.06.03.01 Brinzolamide 
11.06.03.03 Brinzolamide 1% with Timolol 0.5%  Azarga®
11.06.03.03 Brinzolamide 10mg/ml & brimonidine 2mg/ml Simbrinza®
04.08.01 Brivaracetam 
13.05.03 Brodalumab Dermatology
11.08.02 Brolucizumab Beovu®

Beovu is indicated in adults for the treatment of neovascular (wet) age-related macular degeneration (AMD).

 

CCG funded as per NICE TAGs below

 

06.07.01 Bromocriptine 
01.05.02 Budesonide 

Brand as indicated by the specialist

01.05.02 Budesonide Foam enema
03.02 Budesonide Pulmicort turbohaler®
12.02.01 Budesonide 
03.02 Budesonide and formoterol Symbicort®
02.02.02 Bumetanide 
15.02 Bupivacaine hydrochloride 
15.02 Bupivacaine Hydrochloride with Glucose 
15.02 Bupivacaine with Fentanyl 
04.07.02 Buprenorphine patch

Brand Choice :-

TWCCG - Butec 7 day patches

04.10.03 Buprenorphine sub-lingual tablets
06.07.02 Buserelin 

For Fertility Use Only

08.03.04.02 Buserelin 
08.01.01 Busulfan 

NHSE funded through routine commissioning for chemotherapy regimes

03.04.03 C1 Esterase Inhibitors 

This drug is NHSE funded for the indications outlined in the Ex-tariff list as per the following:

NHSE policy (for Cinryze brand in children and prophylactic treatment)

NHSE policy (for acute treatment)

08.01.05 Cabazitaxel Jevtana®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq Drug)

06.07.01 Cabergoline 
08.01.05 Cabozantinib Cometriq®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug).

This drug is funded by the CDF for the indication outlined wihin the CDF list  (Blueteq Drug)

08.01.05 Cabozantinib Cabometyx® Cometriq®

Ths drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug).

Suitable for shared care between specialist and secondary care via network model.

19.03 Cadexomer Iodine 5g Iodoflex

Use

Critically colonised or infected wounds.

Application

Apply to wound surface, removing backing gauze.
Renew when saturated, shown by loss of colour, usually 2-3 times weekly.
Maximum single application is 50 g. Do not exceed 150 g weekly or treatment course of 3 months.
Replace before adherent crust forms.
Once infection is under control, discontinue.
If use is continued after 2 weeks please discuss with the Tissue Viability Service.

Avoid

Sensitivity to Iodine
Use in pregnant or breast feeding women as absorption of iodine can occur.
Patients with severely impaired renal function or history of any thyroid disorder as they are more susceptible to alterations in thyroid metabolism. Consult a specialist if iodine dressing used on extensive areas for more than 2 weeks or if Chronic Kidney Disease grade 4 or 5 or patient is taking lithium.
Do not use with hydrogels.
Data sheet available on www.medicines.org.uk

 

13.03 Calamine lotion 

Self Care Self Care Medicine:
For the reilef of mild sunburn and other minor skin rashes and irritation
For the relief of chickenpox symptoms from 6 months

13.05.02 Calcipotriol 50mcg/g ointment
13.05.02 Calcipotriol 50mcg/g with Betamethasone 500mcg/g foam
13.05.02 Calcipotriol 50mcg/ml scalp solution
13.05.02 Calcipotriol 50micrograms/g with Betamethasone 500mcg/g ointment, gel
06.06.01 Calcitonin (salmon) / Salcatonin 
18 Calcium chloride 
09.05.02.02 Calcium acetate PhosLo®
09.05.02.02 Calcium Acetate Phosex®
09.05.01.01 Calcium Carbonate Adcal
09.05.02.02 Calcium Carbonate Adcal
09.05.01.01 Calcium Carbonate effervescent Sandocal-1000 ®
09.05.01.01 Calcium Chloride injection 
08.01 Calcium Folinate 

NHSE funded as part of routine commissioning for chemotherapy regimes

18 Calcium folinate 
18 Calcium gluconate  
09.05.01.01 Calcium Gluconate injection 
08.01 Calcium Levofolinate 

NHSE funded as part of routine commissioning for chemotherapy regimes

09.02.01.01 Calcium Polystyrene Sulphonate  Calcium Resonium®
A2.04.01.02 Calogen 
06.01.02.03 Canagliflozin 
02.05.05.02 Candesartan 
08.01.03 Capecitabine 

NHSE funded as part of routine commissioning for chemotherapy regimes

10.03.02 Capsaicin 0.025% 

Topical capsaicin should be considered as an adjunct to core treatments for knee or hand osteoarthritis.

10.03.02 Capsaicin 0.075%  Neuropathic pain

Consider capsaicin cream for people with localised neuropathic pain who wish to avoid, or who cannot tolerate oral treatments.

02.05.05.01 Captopril 
04.02.03 Carbamazepine 
04.07.03 Carbamazepine 
04.08.01 Carbamazepine 
06.02.02 Carbimazole 
03.07 Carbocisteine 375mg capsules
03.07 Carbocisteine 750mg/10ml sachets
08.01.05 Carboplatin 

NHSE funded through routine commissioning for chemotherapy regimes

08.01.05 Carboplatin Paraplatin®

NHSE funded through routine commissioning for chemotherapy regimes

08.01.05 Carfilzomib Kyprolis®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug).

This drug is funded by the CDF for the indication outlined within the CDF list. (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model.

11.08.01 Carmellose 
08.01.01 Carmustine 

NHSE funded through routine commissioning for chemotherapy regimes

02.04 Carvedilol 
05.02.04 Caspofungin 
07.04.04 Catheter Patency Solutions 
07.04.04 Catheter Patency Solutions 
07.04.04 Catheter Patency Solutions 
07.04.04 Catheter Patency Solutions 
19.20 Cavilon barrier film 1ml foam applicator (sterile)

Use

Protective transparent barrier film. Alcohol free. Provides up to 72 hours protection before reapplication required. Non cytotoxic. Primary barrier against body fluids, protection from aggressive adhesive products, skin protection around stoma sites, peri-wound protection from exudate.

Application

Apply sparingly to clean dry skin.
The film formulation is pain free on application to broken skin. Will aid adhesion of tapes and adhesive dressings.

Tips

Allow the film to dry completely before applying pads or clothing. Not to be used with other barrier creams or lotions.

Avoid

Not suitable for very wet wounds as difficult to apply.

 

19.20 Cavilon Sachet Durable barrier cream

Use

Highly concentrated cream that acts as a barrier to bodily fluids and as a moisturiser for severely dry or chapped skin.

Application

Apply sparingly to clean dry skin.

Tips

Not to be used with other barrier creams or lotions.

Avoid

The cream can increase the adherence of some adhesive products so should be avoided under adhesive products in people with fragile skin.
Not suitable for very wet wounds as difficult to apply.

 

05.01.02.01 Cefalexin 
05.01.02.01 Cefotaxime 
05.01.02.01 Ceftazidime 
11.03.01 Ceftazidime  

Restricted for Endophthalmitis

05.01.02.03 Ceftazidime/ avibactam Zavicefta®

For ITU use only under the direction of microbiology

05.01.02.01 Ceftriaxone 
11.03.01 Cefuroxime 5% 
05.01.02.01 Cefuroxime axetil 
08.01.05 Ceritinib Zykadia®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model.

10.01.03 Certolizumab Pegol 
13.05.03 Certolizumab pegol 
03.04.01 Cetirizine 

Self Care Self Care Medicine: Bites & stings, contact dermatitis, atopic eczema, dry skin, seasonal allergic rhinitis (hayfever).  Syrup from 2 years, tablets from 6 years

13.02.01 Cetraben ® Cream and Ointment

Self Care Self Care Medicine: Contact dermatitis/atopic eczema/dry skin in adults and children

08.01.05 Cetuximab Erbitux®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq Drug)

04.01.01 Chloral Hydrate Chloral Elixir®, Paediatric, BP 2000
04.01.01 Chloral Hydrate 
08.01.01 Chlorambucil 

NHSE funded through routine commissioning for chemotherapy regimes

05.01.07 Chloramphenicol 
11.03.01 Chloramphenicol 

Self Care Self Care Medicine: Moderate-Severe bacterial conjuctivitis from 2 years
Exceptions & OTC restrictions:
Red flag symptoms
Pregnancy & breastfeeding

 

11.03.01 Chloramphenicol 

Self Care Self Care Medicine: Moderate-Severe bacterial conjuctivitis from 2 years
Exceptions & OTC restrictions:
Red flag symptoms
Pregnancy & breastfeeding

 

12.01.01 Chloramphenicol 5% 
04.01.02 Chlordiazepoxide 
12.03.04 Chlorhexidine 0.2% mouthwash

Self Care Self Care Medicine: Mouth ulcers from 12 years

12.02.03 Chlorhexidine Hydrochloride 0.1%, Neomycin Suphate 0.5% Naseptin®
05.04.01 Chloroquine 

Malaria should always be managed in consultation with someone experienced in managing the disease. Advice can be sought from the on-call infectious disease SpR at Birmingham Heartlands Hospital (via switchboard). 

10.01.03 Chloroquine 
03.04.01 Chlorphenamine 

Self Care Self Care Medicine: Bites & stings, chickenpox, contact dermatitis, atopic eczema, dry skin, seasonal allergic rhinitis (hayfever) - Syrup from 1 year, tablets from 6 years
Scabies (associated itching) - Syrup from 2 years, tablets from 6 years

04.02.01 Chlorpromazine 
14.04 Cholera vaccine Dukoral®

Travel vaccine available on the NHS

Which travel vaccines are free?

12.03.01 Choline Salicylate Bonjela® Adult

Self Care Self Care Medicine: Mouth ulcers from 16 years

01.05.03 Ciclosporin 

Brand as indicated by the specialist

08.02.02 Ciclosporin 

This drug is NHSE funded for the indications outlined within the Ex-Tariff list.

10.01.03 Ciclosporin 
11.99.99.99 Ciclosporin 
13.05.03 Ciclosporin 
09.05.01.02 Cinacalcet 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

Please view the policy from NHSE - Clinical Commissioning Policy

When issued to a patient with Complex Primary Hyperparathyroidism - the medicine is funded within tariff.

When issued to a patient with secondary hyperparathyroidism and on dialysis - this medicine is funded by NHSE

04.06 Cinnarizine 

Self Care Self Care Medicine - Travel sickness over 5 years of age

05.01.12 Ciprofloxacin 
12.01.01 Ciprofloxacin 0.2% 2mg/ml ear drop solution
11.03.01 Ciprofloxacin 0.3% 

2nd line Quinolone

08.01.05 Cisplatin 

NHSE funded through routine commissioning for chemotherapy regimes

04.03.03 Citalopram 
07.04.03 Citrate 

Self Care Self Care Medicine for cystitis in adult women only

08.01.03 Cladribine Leustak®Litak®

The tablet formation of Cladribine (Mavenclad) is NHSE funded for the indication outlined within the Ex-Tariff List. Please note that this approval is only given to Specialised Neuroscience Centres who provide specailised multiple sclerosis services. Please view Cladribine (Mavenclad) entry for details.

Suitable for shared care between specialist and secondary care via network model only where it is a recognised MS centre with specialised nurse support.

05.01.05 Clarithromycin 
05.01.06 Clindamycin 
07.02.02 Clindamycin Dalacin®
13.06.01 Clindamycin 1% Dalacin T®
19.05 Clinimed Gauze Non-sterile swabs

Use

To soak up wound irrigation fluid
To provide padding
To aid application of emollients

Application

Use to cleanse wound bed and surrounding skin

Tips

Soak with cleanser and use to clean wound bed and surrounding skin

Avoid

Direct contact with wound bed

 

19.22 Clinipore Tape 

Use

Permeable non-woven synthetic adhesive tape.

Application

Use for securing dressings.

 

11.08.01 Clinitas Carbomer gel 0.2%

Self Care Self Care Medicine: Mild to moderate dry eye or sore tired eyes
Exceptions & OTC restrictions:
Pre-existing long-term conditions affecting the eyes
Pregnancy & breastfeeding

04.08.01 Clobazam 
13.04 Clobetasol Propionate 0.05% Dermovate®
13.04 Clobetasone Butyrate 0.05% Eumovate®
08.01.03 Clofarabine 

This drug is funded by the CDF for the indication outlined within the CDF list (Blueteq Drug)

06.05.01 Clomifene Citrate 
04.03.01 Clomipramine 
04.08.01 Clonazepam 
04.08.02 Clonazepam 
02.05.02 Clonidine 

Tourette's/Tic disorder

02.09 Clopidogrel 
07.02.02 Clotrimazole 

Self Care Self Care Medicine: Vaginal thrush 16-60 years, 500mg pessary and 2% cream

13.10.02 Clotrimazole 

Self Care Self Care Medicine: Fungal skin infections from 1 year - 1% cream

12.01.01 Clotrimazole 1% 
04.02.01 Clozapine 
02.02.04 Co-amilofruse (furosemide and amiloride) 
05.01.01.03 Co-Amoxiclav 
04.09.01 Co-Beneldopa Madopar®
15.02 Cocaine 
15.02 Cocaine with Adrenaline 
04.09.01 Co-Careldopa Sinemet®
04.09.01 Co-Careldopa and Entacapone 
04.07.01 Co-codamol 30/500 
04.07.01 Co-codamol 8/500 
13.06.02 Co-Cyprindiol 
01.06.02 Co-danthramer 

* Palliative care only*

01.04.02 Codeine Phosphate 
04.07.02 Codeine Phosphate 
10.01.04 Colchicine 
09.06.04 Colecalciferol 25,000 unit liquid Invita D3®
09.06.04 Colecalciferol 800 units Fultium D3®
09.06.04 Colecalciferol and Calcium Carbonate 
02.12 Colesevelam Cholestagel®

Only to be used during supply shortages of alternative bile acid sequestrants. Specialist advice required.

02.12 Colestyramine 
01.09.02 Colestyramine powder 
05.01.07 Colistimethate for nebulisation Colomycin®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

For other indications it can be prescribed in Primary Care on the recommendation of a specialist.

01.01.01 Co-magaldrox 

Self Care Self Care Medicine: Heartburn/Indigestion from 12 years

06.04.01.01 Combined continuous HRT patch Evorel® Conti
06.04.01.01 Combined cyclical HRT patch Evorel® Sequi
09.02.02.01 Compound Sodium Lactate Intravenous Infusion 
06.04.01.01 Conjugated Oestrogens with Medroxyprogesterone Premique low dose®
19.01 Cosmopore E Absorbant perforated adhesive dressing

Use

Wounds healing by primary intention
Absorbent dressing for post-op and surgical wounds
Low exuding wounds

Application

Apply directly to the wound

Tips

Adhesive

Avoid

Heavily exuding wounds

 

05.01.08 Co-trimoxazole 
05.04.08 Co-trimoxazole pneumocystis pneumonia
08.01.05 Crisantaspase Erwinase®

NHSE funded through routine commissioning for chemotherapy regimes

08.01.05 Crizotinib Xalkori®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq Drug)

13.03 Crotamiton Eurax®

Self Care Self Care Medicine: Bites & stings, contact dermatitis and scabies (associated itching) from 3 years

04.06 Cyclizine 
11.05 Cyclopentolate  
11.05 Cyclopentolate Hydrochloride single use 
08.01.01 Cyclophosphamide 

NHSE funded through routine commissioning for chemotherapy regimes

10.01.03 Cyclophosphamide 
08.03.04.02 Cyproterone 
08.01.03 Cytarabine Depocyte®

NHSE funded as part of routine commissioning for chemotherapy regimes

02.08.02 Dabigatran 
08.01.05 Dabrafenib Tafinlar®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

This drug is funded by the CDF for the indication outlined within the CDF list.

08.01.05 Dacarbazine 

NHSE funded through routine commissioning for chemotherapy regimes

08.01.05 Dacomitinib Vizimpro ®

This drug is NHSE funded for the indications outlined within the NICE guidance (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model.

06.07.02 Danazol 
10.02.02 Dantrolene 
18 Dantrolene 
15.01.08 Dantrolene Sodium Intravenous
06.01.02.03 Dapagliflozin Forxiga®

Started for heart failure with reduced ejection fraction under specialist supervision added once 'standard of care' regimen is optimised

Click here for link to PID

05.01.10 Dapsone 
08.01.05 Daratumumab Darzalex®

This drug is CDF funded for the indications outlined within the NICE guidance (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model.

09.01.03 Darbepoetin Alfa Aranesp®
08.03.04.02 Darolutamide Nubeqa®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug).

Suitible for shared care

08.01.05 Dasatinib Sprycel®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug)

08.01.02 Daunorubicin 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list

19.07 Debrisoft 
19.07 Debrisoft Lolly 
09.01.03 Deferasirox Exjade®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

Suitable for prescribing at Specialist Centres. 

01.05.02 Deflazacort Calcort®

Oral steroid used in Duchenne Muscular Dystrophy (DMD) in patients who cannot tolerate prednisolone

08.03.04.02 Degarelix Firmagon®
06.07.04 Demeclocycline hydrochloride 
06.06.02 Denosumab XGEVA®
06.06.02 Denosumab Prolia®

This drug requires an ESCA. SCCG ESCA is currently being reviewed

15.02 Dermogesic spray 
18 Desferrioxamine 
09.01.03 Desferrioxamine Mesilate Desferal®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

Suitable for prescribing at Specialist Centres. 

06.05.02 Desmopressin 
07.03.02.01 Desogestrel Zelleta®

Note - some generic versions of desogestrel contain soyabean oil and it is recommended that there products should not be taken by patients who are allergic to soya or peanuts. In these patients prescribe by brand name that does not contain soyabean oil.

In patients with peanut or soya allergy requiring desogestrel products: Cerelle or cerazette can be used.

06.03.02 Dexamethasone Tablets
11.04.01 Dexamethasone eye drops 
11.04.01 Dexamethasone eye drops preservative free single use

Preservative free products are an option if the patient:
1. Has a preservative allergy
2. Has significant external eye disease
3. Wears soft contact lenses

11.04.01 Dexamethasone intravitreal implant 
10.01.02 Dexamethasone Sodium Phosphate 
12.01.01 Dexamethasone with Framycetin and Gramicidin Sofradex®
12.01.01 Dexamethasone with Neomycin Otomize®
11.04.01 Dexamethasone with Neomycin and Polymyxin B sulphate 
04.04 Dexamfetamine 

Adults and children > 5 years whose ADHD symptoms are responding to lisdexamfetamine but who cannot tolerate the longer effect profile.

08.01 Dexrazoxane Savene®

This drug is NHSE funded for the indication outlined within this policy. If used outside of this policy, an IFR is required.

08.01 Dexrazoxane Cardioxane ®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list as per policy NHS England Reference: 200204P 

Blueteq form required (Blueteq Drug).

(Specialist centres only)

09.02.02.02 Dextran 40 ® 
09.02.02.02 Dextran 70 ® 
04.07.02 Diamorphine 
04.01.02 Diazepam 
04.08.02 Diazepam epilepsy
04.08.03 Diazepam 
10.02.02 Diazepam 
15.01.04.01 Diazepam 
18 Diazepam 
06.01.04 Diazoxide 
10.01.01 Diclofenac 
13.08.01 Diclofenac 3% 
10.03.02 Diclofenac gel 

Self Care Self Care Medicine: For self-limiting musculoskeletal pain, sprains and strains from 14 years of age

08.03.01 Diethylstilbestrol 
02.01.01 Digoxin 
02.01.01 Digoxin specific antibody fragments 
04.07.02 Dihydrocodeine 
05.04.02 Diloxanide 
01.07.04 Diltiazem Cream 2% 
02.06.02 Diltiazem Hydrochloride Tildiem®

TDS dosing

02.06.02 Diltiazem Hydrochloride Angitil SR

BD dosing

02.06.02 Diltiazem Hydrochloride Tildiem LA

OD dosing

02.06.02 Diltiazem Hydrochloride Adizem SR

BD dosing

Second line indication: Patient unable to tolerate 1st line
                                  Manufacturer supply problems with 1st line

02.06.02 Diltiazem Hydrochloride Viazem XL®

DAILY dosing

08.02.04 Dimethyl fumarate Tecfidera®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list 

13.05.02 Dimethyl Fumarate  
07.01.01 Dinoprostone Prostin E2®
07.01.01 Dinoprostone Propess®
02.09 Dipyridamole 
06.06.02 Disodium Pamidronate 
09.05.01.02 Disodium Pamidronate IV 
02.03.02 Disopyramide 
04.10.01 Disulfiram Antabuse®
13.05.02 Dithranol Dithrocream®
02.07.01 Dobutamine 
08.01.05 Docetaxel Taxotere®
01.06.02 Docusate Sodium 
01.02 Domperidone 
04.06 Domperidone 
04.11 Donepezil 
02.07.01 Dopamine 
03.07 Dornase Alfa 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

Policy for primary cilary dyskinesia

Policy for cystic fibrosis

11.06.03.01 Dorzolamide 
11.06.03.03 Dorzolamide 2% with Timolol 0.5% 
11.06.03.02 Dorzolamide 2% preservative free 

Preservative free products are an option if the patient:
1. Has a preservative allergy 
2. Has significant external eye disease
3. Wears soft contact lenses

11.06.03.04 Dorzolamide 2% with timolol 0.5% preservative free Cosopt®

Preservative free products are an option if the patient:
1. Has a preservative allergy 
2. Has significant external eye disease
3. Wears soft contact lenses

03.05.01 Doxapram 
15.01.07 Doxapram 
02.05.04 Doxazosin 
07.04.01 Doxazosin 
08.01.02 Doxorubicin Caelyx® ,
Myocet

This drug is funded by the CDF for the indication outlined within the  CDF list (Blueteq Drug).

05.01.03 Doxycycline 
05.04.01 Doxycycline 

Malaria should always be managed in consultation with someone experienced in managing the disease. Advice can be sought from the on-call infectious disease SpR at Birmingham Heartlands Hospital (via switchboard). 

13.06.02 Doxycycline 

NICE CKS: For moderate acne not responding to topical treatments

05.01.03 DOXYCYCLINE Injection 100 mg in 5mL 
13.02.02 Drapolene Barrier preparation
02.03.02 Dronedarone 

Dronedarone must be initiated by a specialist and only continued under a shared care arrangement for patients where other treatments cannot be used, have failed or is in line with NICE Guidance CG180.

Dronedarone must not be initiated in primary care.

NICE clinical guideline on Atrial Fibrillation (AF) CG 180 puts greater emphasis on rate rather than rhythm control and has clarified the place of dronedarone in the treatment pathway

06.01.02.03 Dulaglutide Trulicity®
  • For the treatment of adults with insufficiently controlled type 2 diabetes mellitus (T2DM) as an adjunct to diet and exercise in addition to oral anti-diabetic medicines
  • or as an add-on to basal insulin Amber.
  • Not recommended for use as monotherapy when metformin is considered inappropriate due to intolerance or contraindications.
04.03.03 Duloxetine 

Restricted Item Restricted to MPFT only

04.07.03 Duloxetine 
07.04.02 Duloxetine 

May be offered as an alternative to surgical treatment in stress incontinence or mixed urinary incontinence

19.12 Duoderm Extra Thin 

Use

Lightly exuding wounds e.g. pressure ulcers and acute wounds.
Aids granulation in a ‘clean’ wound.
Useful for removal of sloughy tissue by promoting autolysis.
May also be used to soften eschar.

Application

Usually left in place for 3-7 days.
The dressing sheets are self-adhesive.
If adherent may be loosened with warmed saline solution.

Tips

Over granulation may occur, if so, substitute with a foam dressing.
Warm before applying to make dressing more pliable.
A 2 cm overlap around the wound is advisable.

Avoid

Heavily exuding wounds. Infected wounds.

 

19.12 Duoderm Signal 

Use

Lightly exuding wounds e.g. pressure ulcers and acute wounds.
Aids granulation in a ‘clean’ wound.
Useful for removal of sloughy tissue by promoting autolysis.
May also be used to soften eschar.

Application

Usually left in place for 3-7 days.
The dressing sheets are self-adhesive.
If adherent may be loosened with warmed saline solution.

Tips

Over granulation may occur, if so, substitute with a foam dressing.
Warm before applying to make dressing more pliable.
A 2 cm overlap around the wound is advisable.

Avoid

Heavily exuding wounds. Infected wounds.

 

08.01.05 Dupilumab 

 

08.01.05 Durvalumab Imfinzi ®

This drug is funded by the CDF for the indication outlined within the CDF list (Blueteq Drug)

02.08.02 Edoxaban 
A2.01.01.02 Elemental 028 Extra 
09.01.04 Eltrombopag 
01.04.02 Eluxadoline 
06.01.02.03 Empagliflozin 
13.02.01 Emulsifying Ointment BP 

Self Care Self Care Medicine: Contact dermatitis/atopic eczema/dry skin in adults and children

02.05.05.01 Enalapril  
08.01.05 Encorafenib Braftovi®

This drug is NHSE funded for the indications outlined within the Ex-Tariff List (Blueteq Drug) 

Suitable for shared care between specialist and secondary care via network model

A2.06.02 Ener-G low-protein 
A2.06.02 Ener-G low-protein egg replacer 
02.08.01 Enoxaparin 
A2.02.02.03 Ensure Compact 
A2.02.02.02 Ensure Plus Creme 
A2.02.02 Ensure Plus Fibre 
A2.02.02.01 Ensure Plus Fibre 
A2.02.01.02 Ensure Plus Juce 
A2.02.02.01 Ensure Plus Milkshake style 
A2.02.02.01 Ensure Plus Savoury 
A2.02.02.01 Ensure Plus Yoghurt style 
A2.02.01 Ensure Shake 
A2.01.02.03 Ensure Twocal 
04.09.01 Entacapone 
08.01.05 Entrectinib 

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq drug)

This drug is funded by the CDF for the indications outlined within the CDF list (Blueteq Drug).

Suitable for shared care between specialist and secondary care via network model.

08.03.04.02 Enzalutamide Xtandi®

This drug is NHSE funded for the indication oulined in the Ex-Tariff list.

02.07.02 Ephedrine 
12.02.02 Ephedrine 0.5% and 1%

Self Care Self Care Medicine: Nasal congestion from 13 years

13.02.01 Epimax ® Cream and Ointment

Self Care Self Care Medicine: Contact dermatitis/atopic eczema/dry skin in adults and children

08.01.02 Epirubicin 2mg/ml

NHSE funded through routine commissioning for chemotherapy regimes

02.02.03 Eplerenone 

For initiation by cardiologist only in patients for whom spironolactone is not appropraite, then continued in primary care.

09.01.03 Epoetin alfa Eprex®
09.01.03 Epoetin beta NeoRecormon®
02.08.01 Epoprostenol 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

02.09 Eptifibatide 
03.07 Erdosteine 

For a maximum of 10 days treatment only.

04.07.04.02 Erenumab Aimovig®
07.01.01 Ergometrine Maleate 
08.01.05 Eribulin Halaven®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model.

08.01.05 Erlotinib Tarceva®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

05.01.02.02 Ertapenem Invanz®
06.01.02.03 Ertugliflozin 
05.01.05 Erythromycin 
13.06.01 Erythromycin 40mg with Zinc Acetate 12mg/mL Zineryt®
04.03.03 Escitalopram 
04.08.01 Eslicarbazepine Zebinix®
02.04 Esmolol 
01.03.05 Esomeprazole 

Self Care Self Care Medicine: Heartburn/Indigestion in adults for up to 2 weeks

04.10.03 Espranor Buprenorphine oral lyophilisate wafers

Approved within MPFT

07.02.01 Estradiol Vagifem®
06.04.01.01 Estradiol with Dydrogesterone Femoston Conti®
06.04.01.01 Estradiol with Dydrogesterone Femoston®
06.04.01.01 Estradiol with Medroxyprogesterone Indivina®
06.04.01.01 Estradiol with Norethisterone Kliofem®
06.04.01.01 Estradiol with Norethisterone Elleste Duet®
07.02.01 Estriol cream Ovestin®
10.01.03 Etanercept Rheumatology
13.05.03 Etanercept 
09.05.01.02 Etelcalcetide Parsabiv®
05.01.09 Ethambutol  
05.01.09 Ethambutol 

Where appropriate doses should be rounded up/down to facilitate the use of the licenced tablets

07.03.01 Ethinylestradiol 20mcg / desogestrel 150mcg Gedarel®20/150

Note - some generic versions of desogestrel contain soyabean oil and it is recommended that there products should not be taken by patients who are allergic to soya or peanut. In these patients prescribe by brand name (using a brand that does not contain soyabean oil).

In patients with peanut or soya allergy requiring desogestrel products: Gedarel can be used

07.03.01 Ethinylestradiol 20mcg / gestodene 75 mcg Millinette®20/75
07.03.01 Ethinylestradiol 30 / Levonorgestrel 150  Levest®
07.03.01 Ethinylestradiol 30mcg / desogestrel 150mcg Gedarel®30/150

Note -  some generic versions of desogestrel contain soyabean oil and it is recommended that there products should not be taken by patients who are allergic to soya or peanuts. In these patients prescribe by brand name (using a brand that does not contain soyabean oil).

In patients with peanut or soya allergy requiring desogestrel products: Gerarel can be used

07.03.01 Ethinylestradiol 30mcg / desogestrel 150mcg Marvelon®

Note - some generic versions of desogestrel contain soyabean oil and it is recommeded that there products should not be taken by patients who are allergic to soya or peanuts. In these patients prescribe by brand (using a brand that does not contain soyabean oil).

In patients with peanut or soya allergy requiring desogestrel products: Gedarel can be used

07.03.01 Ethinylestradiol 30mcg / drospirenone 3 mg Yacella®
07.03.01 Ethinylestradiol 30mcg / gestodene 75mcg Millinette®30/75
07.03.01 Ethinylestradiol 30mcg / gestodene 75mcg Femodene or Femodene® ED
07.03.01 Ethinylestradiol 30mcg / levonorgestrel 150mcg Rigevidon®
07.03.01 Ethinylestradiol 30mcg / levonorgestrel 150mcg Microgynon 30 and Microgynon 30 ED®
07.03.01 Ethinylestradiol 35mcg / norgestimate 250mcg Cilique®
04.08.01 Ethosuximide Emeside®
15.02 Ethyl Chloride Spray
07.03.02.02 Etonorgestrel Implanon®
08.01.04 Etoposide Etopophos® Vepesid®

NHSE funded as part of routine commissioning for chemotherapy regimes

08.01.05 Everolimus Afinitor®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug)

08.01.05 Everolimus Votubia®

This drug is NHSE funded for the indication outlined within the policy

 

02.12 Evolocumab 
08.03.04.01 Exemestane 
19.18 Exufiber 

Use

Unique fibre dressing with patented Hydrolock technology for a wide range of exuding wounds. Leg and foot ulcers, pressure ulcers, partial thickness burns, surgical wounds, donor sites, malignant wounds.

Application

The dressing should cover the entire wound. It should overlap the surrounding skin by 1-2 cm for the smaller sizes and 5 cm for the larger sizes. Loosely pack ribbon or sheet to allow room for swelling of the dressing.

Tips

Can be used under compression therapy.

Avoid

Do not use on dry wounds or full thickness burns.

 

02.12 Ezetimibe 

For statin intolerence

02.11 Factor IX Fraction, Dried 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

 

02.11 Factor VIII Fraction, Dried 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

02.11 Factor XIII Fraction, Dried 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

05.03.02.01 Famciclovir Famvir®

2nd line shingles

A2.06.02 Fate low-protein all-purpose mix 
10.01.04 Febuxostat 
02.06.02 Felodipine 
02.12 Fenofibrate 

Black non-formulary - 67mg

04.07.02 Fentanyl 

All patients receiving opioid doses of >50 mg/day morphine equivalent should be reviewed regularly (at least annually) to detect emerging harms and consider ongoing effectiveness. Pain specialist advice or review should be sought at doses >90 mg/day morphine equivalent.

Brand Choice:-

TWCCG - Mezolar Matrix (most cost effective)

04.07.02 Fentanyl 

Only licensed for use in breakthrough pain in cancer.

 

15.01.04.03 Fentanyl 
09.01.01.02 Ferric Carboxymaltose Ferinject®
09.01.01.01 Ferrous Fumarate 
09.01.01.01 Ferrous Fumarate Syrup 140mg/5ml
09.01.01.01 Ferrous Gluconate 
09.01.01.01 Ferrous Sulphate 
A2.02.02.01 Fesubin Thickened 
03.04.01 Fexofenadine 
06.01.01.01 Fiasp® 
10.01.03 Filgotinib  Jyseleca®
09.01.06 Filgrastim 
06.04.02 Finasteride 
08.02.04 Fingolimod 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list (BlueTeq Drug)

19.02 Flaminal Forte 15g tube

Use

Alginate gel (protease modulator) containing two antimicrobial enzymes, glucose oxidase and lactoperoxidase which exert their effect without damaging healthy skin cells. Debrides the wound and manages moisture balance

Application

Apply directly to wound bed.   Secondary dressing required

Tips

Flaminal Forte for moderate/heavy exudate

Avoid

Avoid if sensitive to alginate dressings/polyethylene glycol

Not suitable for full-thickness (third degree) burns

19.02 Flaminal Hydro 15g tube

Use

Alginate gel (protease modulator) containing two antimicrobial enzymes, glucose oxidase and lactoperoxidase which exert their effect without damaging healthy skin cells. Debrides the wound and manages moisture balance

Application

Apply directly to wound bed.   Secondary dressing required

Tips

Flaminal Hydro for light/moderate exudate

Avoid

Avoid if sensitive to alginate dressings/polyethylene glycol

Not suitable for full-thickness (third degree) burns

 

02.03.02 Flecainide 
19.06 Flex-Ban Short stretch bandage

Use

Primary layer of compression bandaging.

Application

Apply in a spiral with 50% overlap from toe to knee.
Apply as manufactures instructions.

Tips

May be left in place for 7 days.

Avoid

May require stockinette prior to application if allergies to the wadding are identified or suspected.

 

05.01.01.02 Flucloxacillin 
05.02 Fluconazole 

Self Care Self Care Medicine: Vaginal Thrush from 16 - 60 years (non-pregnant women)

07.02.02 Fluconazole 

Self Care Self Care Medicine: Vaginal Thrush from 16 - 60 years (non-pregnant women)

08.01.03 Fludarabine Phosphate Fludara®

NHSE funded as part of routine commissioning for chemotherapy regimes

06.03.01 Fludrocortisone 
15.01.07 Flumazenil 
18 Flumazenil 
12.01.01 Flumetasone 0.02% with Clioquinol 1% 
11.04.01 Fluocinolone intravitreal implant 
11.08.02 Fluorescein Sodium Single use
11.04.01 Fluorometholone 
08.01.03 Fluorouracil 

NHSE funded as part of routine commissioning for chemotherapy regimes

11.99.99.99 Fluorouracil 
13.08.01 Fluorouracil 
04.03.03 Fluoxetine 
04.02.01 Flupentixol 
04.02.02 Flupentixol Decanoate 
04.02.02 Fluphenazine Decanoate 
12.02.01 Fluticasone furoate 27.5 micrograms Avamys®
03.02 Fluticasone furoate & vilanterol 
03.02 Fluticasone furoate, vilanterol trifenatate, umeclidinium bromide  Trelegy®
12.02.01 Fluticasone Propionate 400mcg Flixonase Nasule®
12.02.01 Fluticasone Propionate 50 micrograms 
03.02 Fluticasone propionate and formoterol Flutiform®
19.10 FoamLite adhesive 
09.01.02 Folic Acid 
02.08.01 Fondaparinux 

According to the ACS pathway.

03.01.01.01 Formoterol Easyhaler
03.02 Formoterol fumarate dihydrate/glycopyrronium/budesonide Trixeo Aerosphere®

Trixeo Aerosphere is a 'high carbon' pMDI (pressurised metered dose inhaler)

Dry powder inhalers are favoured for environmental reasons

It can be used with the Aerochamber Plus Vu spacer

03.02 Formoterol fumarate, beclometasone dipropionate and glycopyrronium bromide Trimbow®
05.01.07 Fosfomycin 

On recommendation of microbiology only

04.07.04.02 Fremanezumab Ajovy®

Solution for injection in pre-filled syringe

 

NICE TA631: Fremanezumab for preventing migraine

08.03.04.01 Fulvestrant Faslodex®
02.02.02 Furosemide 
11.03.01 Fusidic Acid 
13.10.01.02 Fusidic Acid 2% Fucidin®
04.07.03 Gabapentin 
04.08.01 Gabapentin 
04.11 Galantamine 

Brand choice:-

TWCCG - Luventa XL (branded generic)

04.07.04.02 Galcanezumab Emgality®

Solution for injection in pre-filled syringe

 

NICE TA659: Galcanezumab for preventing migraine

05.03.02.02 Ganciclovir 
01.01.02 Gaviscon Advance 

Self Care Self Care Medicine: Heartburn/Indigestion from 12 yrs

08.01.05 Gefitinib Iressa®

This drug is NHSE funded for tthe indication outlined within the Ex-Tariff list.

08.01.03 Gemcitabine Gemzar®

NHSE funded as part of routine commissioning for chemotherapy regimes

07.01.01 Gemeprost 
08.02.03 Gemtuzumab Mylotarg

This drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug)

05.01.04 Gentamicin 
11.03.01 Gentamicin 
12.01.01 Gentamicin 0.3% 
11.03.01 Gentamicin single use 
08.01.05 Gilteritinib 

This drug is NHSE funded for the indications outlined within the Ex-Tariff list.

Suitable for shared care between specialist and secondary care via network model.

08.02.04 Glatiramer Acetate Copaxone®

This drug is NHSE funded for the indications outllined within the Ex-Tariff list (Blueteq Drug)

06.01.02.01 Gliclazide 80mg  
06.01.02.01 Gliclazide modified release 
06.01.02.01 Glimepiride 
06.01.04 Glucagon HypoKit
18 Glucagon GlucaGen® Hypokit
06.01.04 GlucoGel ® 
06.01.01.03 GlucoRX Care Point 4mm, 5mm, and 6mm

4mm needle are deemed to be the safest pen needle for adults and children regardless of age, gender and Body Mass Index (BMI).

For patients currently using longer pen needle lengths (8mm, 12mm), it is advisable to change to a shorter needle length (6mm or less) but only after discussion with a healthcare professional, to ensure they receive advice on the correct injection technique.

06.01.01.03 GlucoRx safety 5mm

Safety pen needles CAN be prescribed on FP10 for use by people who are not healthcare professionals and are not employees in the healthcare sector if there is a risk of disease transmission

 

09.02.02.01 Glucose Intravenous 
01.06.02 Glycerol 

Self Care Self Care Medicine: Constipation (acute) - from 18 years

02.06.01 Glyceryl Trinitrate Transiderm-Nitro®
02.06.01 Glyceryl Trinitrate 
18 Glyceryl Trinitrate 
01.07.04 Glyceryl Trinitrate 0.4% 
02.06.01 Glyceryl Trinitrate 500mcg 
07.04.04 Glycine 
15.01.03 Glycopyrronium 
01.05.03 Golimumab Gastroenterology
This drug is NHSE funded for the indication outlined within the Ex-Tariff list.
NHSE commissioned for Paediatric Indications (where Adult TA available)
 
CCG funded as per NICE TAG below
10.01.03 Golimumab 
06.07.02 Goserelin 
08.03.04.01 Goserelin Zoladex®
08.03.04.02 Goserelin Zoladex®
08.03.04.02 Goserelin Zoladex® LA
04.06 Granisetron 
19.13 Granugel hydrocolloid gel

Use

Superficial, deep, dry, sloughy and necrotic wounds as releases moisture into wound.
May be used in the presence of aerobic or anaerobic infection but systemic antibiotics should also be given. Aids granulation in clean wound.
Consider gently scoring hard black eschar to allow better penetration of gel.

Application

Gel must be applied to a minimum depth of 5 mm to prevent drying out at the edges.
Secondary dressing required.

Tips

Hydrogels are strictly single use items.

Avoid

Heavily exuding wounds.
Use with caution if infection present.

 

03.04.02 Grass pollen extract Grazax®

Must be prescribed in line with CCG Joint Commissioning Policy and accordance with guidance from the tertiary centre.

04.04 Guanfacine 
13.05.03 Guselkumab dermatology
14.04 Haemophilus influenzae type B Combined Vaccine Menitorix®

Order via IMMFORM WEBSITE

PGD - see chapter link above

03.01.05 Haleraid ® 
04.02.01 Haloperidol 
04.02.03 Haloperidol mania and hypomania
04.02.02 Haloperidol Decanoate 
02.08.01 Heparin 
02.08.01 Heparin 
14.04 Hepatitis A vaccine Avaxim, Havrix, Vaqta
14.04 Hepatitis A vaccine with Typhoid vaccine Hepatyrix, Viatim
14.05.02 Hepatitis B immunoglobulin HBIG
14.04 Hepatitis B vaccine 

Hepatitis B vaccine may be provided by the NHS provided the patient meets the inclusion criteria specified in the PGD - see chapter link above

For other groups, the vaccine IS NOT available on the NHS and should be obtained through their employer's occupational health department or via a travel clinic

06.01.01.01 Humalog® 
06.01.01.02 Humalog®  Mix 25, Mix 50
06.05.01 Human Menopausal Gonadotrophins Menopur®

For Fertility Use Only

14.04 Human papilloma virus vaccine Gardasil®

order via IMMFORM WEBSITE

PGD - see chapter link above

06.01.01.02 Humulin® I 
06.01.01.02 Humulin® M3 
06.01.01.01 Humulin® S 
10.03.01 Hyaluronidase 
11.99.99.99 Hyaluronidase 
02.05.01 Hydralazine 
01.05.02 Hydrocortisone Foam enema
01.05.02 Hydrocortisone 
06.03.02 Hydrocortisone 
06.03.02 Hydrocortisone sodium phosphate 
06.03.02 Hydrocortisone sodium succinate 
13.04 Hydrocortisone 1% cream 

Self Care Self Care Medicine: Irritant contact dermatitis, allergic contact dermatitis, insect bite reactions and mild to moderate eczema from 10 years

13.04 Hydrocortisone 1% with Clotrimazole 1% 
12.03.01 Hydrocortisone 2.5mg  muco-adhesive buccal tablets

Self Care Self Care Medicine:  Mouth ulcers from 12 years

12.01.01 Hydrocortisone Acetate 1% with Gentamicin 0.3% Gentisone® HC
12.01.01 Hydrocortisone with Neomycin and Polymyxin Otosporin®
19.09 Hydrofilm dressing 

Use

Mildly exuding wounds.
Primary or secondary dressing.
Provides a moist healing environment.

Application

May be applied as a whole piece or cut into strips.
Apply sticky side to wound or dressing and do not forget to remove outer layer.
May be worn for 7 days.

Tips

Must not be applied under tension, consider swelling.
Must not be used as a secondary dressing over foams.
Leave at least 2 cm around wound.

Avoid

Heavily exuding wounds.
Full thickness wounds involving muscle, tendon or bone or third degree burns.
Fragile skin.

 

12.03.04 Hydrogen Peroxide 
13.11 Hydrogen Peroxide 1% cream Crystacide®

For patients with localised, non-bullous IMPETIGO if they are not systemically unwell or at risk of developing complications. 
Self Care Self Care Medicine

 

13.02.01 Hydromol ® Ointment 

Self Care Self Care Medicine: Contact dermatitis/atopic eczema/dry skin in adults and children

09.01.02 Hydroxocobalamin 
18 Hydroxocobalamin Cyanokit®
08.01.05 Hydroxycarbamide Hydrea®
09.01.03 Hydroxycarbamide 
10.01.03 Hydroxychloroquine 
13.05.03 Hydroxychloroquine 
11.08.01 Hydroxyethylcellulose Minims® Artificial Tears
03.04.01 Hydroxyzine 
01.02 Hyoscine Butylbromide 

1st choice antispasmotic = mebeverine 135mg

 

04.06 Hyoscine Hydrobromide 

Amber Amber - Hypersalivation

15.01.03 Hyoscine Hydrobromide 
11.08.01 Hypromellose 0.3% 

Self Care Self Care Medicine:
Mild bacterial conjunctivitis from 2 years.
Mild to moderate dry eye or sore tired eyes
Exceptions & OTC restrictions:
Pre-existing long-term conditions affecting the eyes
Pregnancy & breastfeeding

06.01.01.02 Hypurin® Bovine Isophane 
06.01.01.01 Hypurin® Bovine Neutral 
06.01.01.02 Hypurin® Bovine Protamine Zinc 
06.01.01.02 Hypurin® Porcine 30/70 Mix 
06.01.01.02 Hypurin® Porcine Isophane 
06.01.01.01 Hypurin® Porcine Neutral 
06.01.01.02 Hypurin®Bovine Lente 
09.05.01.02 Ibandronate IV 
06.06.02 Ibandronic Acid 
06.06.02 Ibandronic Acid injection 
08.01.05 Ibrutinib Imbruvica®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq drug)

This drug is funded by the CDF for the indications outlined within the CDF list (Blueteq Drug).

Suitable for shared care between specialist and secondary care via network model.

10.01.01 Ibuprofen 

Self Care Self Care Medicine
For the relief of mild - moderate pain including: Headache, migraine, fever, symptoms of cold & flu, dental pain, back pain, period pain, neuralgia, rheumatic & muscular pain and  arthritis from 12 years

10.03.02 Ibuprofen 10% gel 

Self Care Self Care Medicine:
For the topical treatment of backache, rheumatic & muscular pain, sprains & strains, neuralgia and symptomatic relief of pain due to non-serious arthritic conditions.
From 12 years via a pharmacy.

10.03.02 Ibuprofen 5% gel 

Self Care Self Care Medicine:
For the topical treatment of backache, rheumatic & muscular pain, sprains & strains, neuralgia and symptomatic relief of pain due to non-serious arthritic conditions.
From 12 years via a pharmacy, 14 years elswhere

10.01.01 Ibuprofen oral suspension 100mg/5ml

Self Care Self Care Medicine:
For many conditions including: Sore throat, teething pain, toothache, headache, minor aches & pains, symptoms of cold & flu, earache, dental pain, back pain, sprains & strains, mild-moderate muscular pain, post-immunisation pyrexia and reduction of fever from 3 months (weighing >5kg) to 12 years

03.04.03 Icatibant 
08.01.02 Idarubicin Zavedos®

NHSE funded through routine commissioning for chemotherapy regimes

08.01.05 Idelalisib Zydelig®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list.

Suitable for shared care between specialist and secondary care via network model.

08.01.01 Ifosfamide 

NHSE funded through routine commissioning for chemotherapy regimes

02.05.01 Iloprost injection  
02.05.01 Iloprost nebules 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

08.01.05 Imatinib Gilvec®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

09.08.01 Imiglucerase Cerezyme®

SaTH is not a specialist centre.

This drug is NHSE funded for the indication outlined withn the Ex-Tariff list.

SPECIALIST CENTRE ONLY.

04.03.01 Imipramine 
13.08.02 Imiquimod 
02.02.01 Indapamide 
07.01.01.01 Indometacin 
10.01.01 Indometacin 
14.04 Infanrix Hexa 

Order via IMMFORM WEBSITE

PGD - see chapter link above

 

14.04 Infanrix IPV ® 

Order via IMMFORM WEBSITE

PGD - see chapter link above

14.04 Infanrix-IPV+Hib 

Order from IMMFORM WEBSITE

PGD - see chapter link above

01.01.02 Infant Gaviscon ® 
A2.03.01 Infatrini Peptisorb 
01.05.03 Infliximab 
This drug is NHSE funded for the indication outlined within the Ex-Tariff list.
NHSE commissioned for Paediatric Indications (where Adult TA available)
 
Biosimilar available: If more than one treatment is suitable, the most cost-effective option should be selected.
 
 
 
CCG funded as per NICE TAGs below
10.01.03 Infliximab 
13.05.03 Infliximab 
14.04 Influenza vaccine  

order via IMMFORM WEBSITE

PGD - see chapter link above

14.04 Influenza vaccine, nasal Fluenz Tetra

order via IMMFORM WEBSITE

PGD - see chapter link above

02.06.04 Inositol Nicotinate 
06.01.01.02 Insulatard® 
08.02.04 Interferon Alfa 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list

08.02.04 Interferon Alfa Roferon-A®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list

08.02.04 Interferon Beta Avonex®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq Drug)

08.02.04 Interferon Beta Rebif®

This drug is NHSE funded for the indications outlined within the Ex-Tariff (Blueteq Drug)

08.02.04 Interferon Beta Betaferon®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq Drug)

08.02.04 Interferon beta Extavia®

This drug is NHSE funded for the indication outlined in the Ex-Tariff list

09.03 Intralipid 20% 
07.03.04 Intra-uterine Contraceptive Devices 
07.03.02.03 Intra-uterine Progestogen Only System Mirena®

Effective for up to 5 years

07.03.02.03 Intra-uterine Progestogen Only System Jaydess®

Effective for up to 3 years

06.02.02 Iodine 2% aqueous oral solution 
08.01.05 Ipilimumab Yervoy®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

03.01.02 Ipratropium Bromide 
03.01.02 Ipratropium Bromide Nebules
02.05.05.02 Irbesartan 
08.01.05 Irinotecan Hydrochloride 

NHSE funded through routine commissioning for chemotherapy regimes

08.01.05 Irinotecan hydrochloride trihydrate  Onivyde®

NHSE funded as part of routine commissioning for chemotherapy regimes

09.01.01.02 Iron Dextran CosmoFer®
09.01.01.02 Iron Sucrose Venofer®
08.02 Isatuximab Sarclisa®

This drug is funded by the CDF for the indications outlined within the CDF list (Blueteq Drug)

Suitible for shared care

SARCLISA is indicated, in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (MM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (PI) and have demonstrated disease progression on the last therapy.

15.01.02 Isoflurane 
05.01.09 Isoniazid 

Where appropriate doses should be rounded up/down to facilitate the use of the licenced tablets

05.01.09 Isoniazid 
02.07.01 Isoprenaline 
02.06.01 Isosorbide Mononitrate Mononil® XL
13.06.02 Isotretinoin 
01.06.01 Ispaghula Husk 

Self Care Self Care Medicine: Constipation (acute) from 6 years

05.02 Itraconazole 
02.06.03 Ivabradine 
13.10.04 Ivermectin 
08.01.05 Ixazomib Ninlaro®

This drug is commissioned for the indication outlined within the Ex-Tariff list with an IFR approval requirement for specialist centres.

This drug is funded by the CDF for the indication outlined within the CDF list (Blueteq Drug)

 Suitable for shared care between specialist and secondary care via network model.

13.05.03 Ixekizumab dermatology
A2.01.01.01 Jevity 
A2.01.02.01 Jevity 1.5 kcal 
A2.01.02.02 Jevity Plus 
A2.01.02.02 Jevity Plus HP 
A2.01.02.02 Jevity Promote 
A2.06.02 Juvela low-protein 
A2.06.02 Juvela low-protein 
A2.06.02 Juvela low-protein 
19.19 K-Band 
15.01.01 Ketamine injection 
11.08.02 Ketorolac Acular®
15.01.04.02 Ketorolac 
11.04.02 Ketotifen preservative free 250mcg/ml Unit dose

Restricted Item Restricted for patients who require Preservative Free treatment

A2.03.02 Kindergen 
19.21 k-Lite 

Use

Lightweight knitted bandage consisting of viscose, nylon and elastomeric yarn

Application

Provides type 2 light support. Designed for use on sprains or strains and for the prevention of oedema

Tips

Latex free

 

19.06 Ko-Flex Bandage 

Retained as top layer for components

19.06 K-Plus bandage 
19.06 K-Soft 
02.04 Labetalol 
02.06.02 Lacidipine 
04.08.01 Lacosamide  
01.06.04 Lactulose 

Self Care Self Care Medicine: Constipation (acute) from1 year

05.03.03.01 Lamivudine 
04.02.03 Lamotrigine 
04.08.01 Lamotrigine 
06.01.06 Lancets FastClix Drum®

Only for patients who have been identified as having needle phobia, visual impairment or dexterity problems

06.01.06 Lancets CareSens®
06.01.06 Lancets (first line) AgaMatrix®ultra-thin lancets 0.35mm/28G

Most cost effective option

08.03.04.03 Lanreotide Somatuline Autogel®
08.03.04.03 Lanreotide Somatuline® LA
01.03.05 Lansoprazole 
09.05.02.02 Lanthanum Fosrenol ®

For indications outside of the Ex-Tariff list, this drug needs to be initiated and dose titrated by a renal specialist.

09.05.02.02 Lanthanum 

This drug is NHSE funded for the indications outlined within the Ex-Tariff list

06.01.01.02 Lantus® 
08.01.05 Larotrectinib Vitrakvi

This drug is funded by the CDF for the indication outlined within the CDF list (Blueteq Drug)

11.06.01.01 Latanoprost 
11.06.01.03 Latanoprost 0.005% with Timolol 0.5% 
10.01.03 Leflunomide 
08.02.04 Lenalidomide  Revlimid®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list. (Blueteq Drug).

This drug is funded by the CDF for the indications outlined within the CDF list. (Blueteq Drug).

Suitible for shared care

09.01.06 Lenograstim 
08.01.05 Lenvatinib Lenvima®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq Drug).

Suitable for shared care between specialist and secondary care via network model.

02.06.02 Lercanidipine 
08.03.04.01 Letrozole 

NHSEHomecare for fertility

06.07.02 Leuprorelin 
08.03.04.02 Leuprorelin Acetate Prostap® SR
08.03.04.02 Leuprorelin Acetate Prostap® 3
06.01.01.02 Levemir® 
04.08.01 Levetiracetam 
09.08.01 Levocarnitine Carnitor®
05.01.12 Levofloxacin 
05.01.12 Levofloxacin 

Levofloxacin is approved for antimicrobial prophylaxis for the first 12 weeks of Myeloma therapy in newly diagnosed patients. This will be prescribed and supplied by the hospital as part of the patients Myeloma treatment.

11.03.01 Levofloxacin 
04.06 Levomepromazine 
07.03.05 Levonorgestrel 1500mg emergency contraception
06.02.01 Levothyroxine 
04.07.03 Lidocaine  

Post-herpetic neuralgia only

Treatment should be re-evaluated after 2-4 weeks. If no response during this time treatment must be discontinued as potential risks may outweigh benefits.

Long-term use - treatment must be reassessed at regular intervals to decide whether the amount of plasters needed to cover the painful area can be reduced, or if the plaster-free period can be extended.

15.02 Lidocaine 1% 

For minor procedures in Primary Care

12.03.01 Lidocaine 10% spray 
15.02 Lidocaine 2.5% with Prilocaine 2.5% EMLA®
15.02 Lidocaine with Adrenaline 
15.02 Lidocaine with tetracaine 
15.02 Lidocaine2% with Chlorhexidine 0.25% Instillagel®
01.06.07 Linaclotide 
06.01.02.03 Linagliptin 
05.01.07 Linezolid 
13.02.01 Liquid and White Soft Paraffin Ointment (50:50) 

Self Care Self Care Medicine: Contact dermatitis/atopic eczema/dry skin in adults and children

11.08.01 Liquid Paraffin Preservative Free eye ointment

Preservative free products are an option if the patient:
1. Has a preservative allergy 
2. Has significant external eye disease
3. Wears soft contact lenses

Self Care Self Care Medicine: Mild to moderate dry eye or sore tired eyes
Exceptions & OTC restrictions:
Pre-existing long-term conditions affecting the eyes
Pregnancy & breastfeeding

06.01.02.03 Liraglutide Saxenda®

ONLY to be prescribed by Tier 3 Weight Management Services

For weight loss/obesity

Use according to NICE guidance

Prescribe by brand (Saxenda®) to avoid patients inadvertently receiving a different product licensed for type 2 diabetes

06.01.02.03 Liraglutide Victoza®
  • For the treatment of adults with insufficiently controlled type 2 diabetes mellitus (T2DM) as an adjunct to diet and exercise in addition to oral anti-diabetic medicines
  • or as an add-on to basal insulin Amber.
  • Not recommended for use as monotherapy when metformin is considered inappropriate due to intolerance or contraindications.
  • THIS IS FOR DIABETES ONLY. Prescribe by brand (Victoza®) to avoid patients inadvertently receiving a different brand licensed for obesity.
04.04 Lisdexamfetamine 
02.05.05.01 Lisinopril 
04.02.03 Lithium Carbonate 

Lithium should be prescribed by brand, ensure the monitoring requirements are met

Preferred brand = Priadel

04.02.03 Lithium Citrate Li-Liquid®

509mg/5ml equivalent to 200mg Lithium Carbonate
1018mg/5ml equivalent to 400mg Lithium Carbonate

 

04.02.03 Lithium Citrate Priadel®

520mg/5ml equivalent to 204mg Lithium Carbonate

04.03.01 Lofepramine 
04.10.03 Lofexidine 
08.01.01 Lomustine 

NHSE funded through routine commissioning for chemotherapy regimes

01.04.02 Loperamide 

Self Care Self Care Medicine: Acute diarrhoea from 12 years

A2.06.02 Loprofin low-protein 
A2.06.02 Loprofin low-protein 
A2.06.02 Loprofin low-protein 
A2.06.02 Loprofin low-protein 
A2.06.02 Loprofin low-protein 
A2.06.02 Loprofin low-protein 
A2.06.02 Loprofin low-protien 
A2.07 Loprofin PKU Drink 
03.04.01 Loratadine 

Self Care Self Care Medicine: Bites & stings, contact dermatitis, atopic eczema, dry skin and seasonal allergic rhinitis (hay fever) from 2 years

04.01.02 Lorazepam 
04.08.02 Lorazepam 
15.01.04.01 Lorazepam 
18 Lorazepam 
08.01.05 Lorlatinib 

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq Drug)

 

02.05.05.02 Losartan 
04.02.01 Lurasidone 
09.01.04 Lusutrombopag 
13.06.02 Lymecycline Tetralysal®300

NICE CKS: For moderate acne not responding to topical treatments

02.05.01 Macitentan 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

18 Macrogol '3350' Klean-Prep®
01.06.04 Macrogol oral powder 
09.05.01.03 Magnesium Aspartate Magnaspartate®
09.05.01.03 Magnesium Sulphate IV 
13.10.04 Malathion 0.5% Derbac-M®

For scabies treatment

 

02.02.05 Mannitol 
03.07 Mannitol inhalation 
14.04 Measles, Mumps and Rubella Vaccine, Live (MMR) MMR VaxPRO or Priorix

order via IMMFORM WEBSITE

PGD - see chapter link above

05.05.01 Mebendazole 

Self Care Self Care Medicine: Threadworms from 2 years of age

01.02 Mebeverine 135mg 
06.04.01.02 Medroxyprogesterone Acetate Provera®
07.03.02.02 Medroxyprogesterone Acetate 
08.03.02 Medroxyprogesterone Acetate Provera®
10.01.01 Mefenamic Acid 
05.04.01 Mefloquine Lariam®

Malaria should always be managed in consultation with someone experienced in managing the disease. Advice can be sought from the on-call infectious disease SpR at Birmingham Heartlands Hospital (via switchboard). 

08.03.02 Megestrol Acetate Megace®
04.01.01 Melatonin 10mg/5ml

May be considered where Melatonin 2mg MR tablets are not suitable

04.01.01 Melatonin  modified release

Amber Amber -children.

Black Black - Slenyto brand

08.01.01 Melphalan 

NHSE funded through routine commissioning for chemotherapy regimes

04.11 Memantine 
09.06.06 Menadiol Sodium Phosphate 
14.04 Meningococcal A, C, W135, and Y conjugate vaccine Menveo®or Nimenrix®

Order via IMMFORM WEBSITE

PGD - see chapter link above

14.04 Meningococcal group B Vaccine Bexsero®

Order via IMMFORM WEBSITE

PGD - see chapter link above

 

19.10 Mepilex 

Use

Mepilex is a soft silicone contact layer with a film backing and safetac technology, designed to treat a wide range of low to moderate exuding acute and chronic wounds in all healing stages.

Application

Apply as a primary or secondary dressing suitable for leg and foot ulcers, pressure ulcers and traumatic wounds.

Tips

Non-traumatic to the wound and surrounding skin on removal.
Can be used in conjunction with compression therapy.

Avoid

Avoid heavily exuding wounds.

 

19.04 Mepilex Ag 
 

MUST be prescribed as a course of treatment
MUST be reviewed every 2-weeks
Ongoing treatment after 2-weeks MUST be discussed with a specialist

Use

Low to moderately exuding wounds.
Leg and foot ulcer, pressure ulcers, partial thickness burns.
May be used on infected wound as part of a treatment regime under supervision of a qualified healthcare professional.

Application

Apply directly to wound bed.

Tips

Leave at least 2 cm around wound.
Reduces pain and trauma during dressing changes.
Contains silicone.

Avoid

Dry wounds.
Do not use on patients with known sensitivity to silver. Do not use during radiation treatment or X-ray, ultrasound, cardioversion.

 

19.10 Mepilex Border 

Use

 

Low to moderate exudate. For use on fragile skin. Reduces pain and trauma during dressing changes.
Leg ulcers, pressure ulcers, diabetic ulcers.

Application

 

Apply directly to wound bed.
Will require bandage or fixing tape.

Tips

 

Easier to apply with moistened gloved hands.
Leave at least 2 cm around wound.
May be useful if patient is highly sensitised.
Contains silicone.
Can be cut to fit unusual locations.
To be cost effective may be left in place for 7 days without removing.

Avoid

Dry or heavily exuding wounds.
Avoid very dry skin.
Avoid using on patients with known silicone allergy.
Do not use when NA Ultra could be used.

 

19.10 Mepilex XT 

Use

Mepilex XT is a soft, conformable foam dressing with safetac technology, designed to treat a wide range of low to moderate exuding acute and chronic wounds in all healing stages.

Application

Apply as a primary or secondary dressing suitable for leg and foot ulcers, pressure ulcers and traumatic wounds.

Tips

Non-traumatic to the wound and surrounding skin on removal.
Can be used in conjunction with compression therapy.

Avoid

Avoid heavily exuding wounds.

 

19.24 Mepitel One dressing

Use

Apply directly to wound bed.
Use for traumatic wounds, epithelialising and granulating wounds, burns, blisters and leg ulcers.
May be used beneath multi-layer compression.

Application

Apply directly to wound bed.
Secondary dressings may be changed as necessary.

Tips

Easier to apply with moistened gloved hands.
Leave at least 2 cm around wound.
May be useful if patient is highly sensitised.
Contains silicone.
To be cost effective may be left in place for 14 days without removing; the wound can be irrigated through the dressing.

Avoid

Do not use when NA Ultra could be used.
Avoid using on patients with known silicone allergy.

 

15.02 Mepivacaine 
01.05.03 Mercaptopurine  Gastroenterology

 

 

08.01.03 Mercaptopurine Puri-Nethol® Xaluprine®

NHSE funded as part of routine commissioning for chemotherapy regimes

05.01.02.02 Meropenem Meronem®
01.05 Mesalazine 

Formulary brand choice: OCTASA
Brand as indicated by specialist

 

 

08.01 Mesna 

NHSE funded through routine commissioning for chemotherapy regimes

18 Mesna 
13.02.02 Metanium Barrier preparation

Self Care Self Care Medicine: Nappy rash in babies and children

02.07.02 Metaraminol 
06.01.02.02 Metformin 
06.01.02.02 Metformin Hydrochloride SR 

SR preparations are restricted to patients who have not tolerated plain metformin.

Brand Choices:-

TWCCG & SCCG Sukkarto SR or Metabet SR (branded generic)

04.07.02 Methadone 
04.10.03 Methadone  1mg/1ml oral solution
05.01.13 Methenamine Hippurate Hiprex®

2nd line prophylaxis - recurrent UTI in non-pregnant women

01.05.03 Methotrexate Gastroenterology
08.01.03 Methotrexate 

NHSE funded as part of routine commissioning for chemotherapy regimes

10.01.03 Methotrexate  oral
10.01.03 Methotrexate s/c rheumatology
13.05.03 Methotrexate 

 

BlueTeq    For subcutaneous injection only

13.05.02 Methoxypsoralen 
02.05.02 Methyldopa 
04.04 Methylphenidate 
04.04 Methylphenidate Hydrochloride MR 

Brand choice: Xenidate XL or Xaggitin XL

06.03.02 Methylprednisolone 
10.01.02 Methylprednisolone Acetate Depo-Medrone®
10.01.02 Methylprednisolone Acetate Depo-Medrone® with Lidocaine
01.02 Metoclopramide 
04.06 Metoclopramide 
02.02.01 Metolazone 
02.04 Metoprolol 
05.01.11 Metronidazole 
05.04.02 Metronidazole 
05.04.03 Metronidazole 
05.04.04 Metronidazole 
07.02.02 Metronidazole Zidoval®
13.06 Metronidazole 0.75% Cream and Gel

Brand preference and size:  ROZEX 30g

13.10.01.02 Metronidazole 0.75% gel  

For infected tumours and ulcers - ANABACT 15g or 30g

02.03.02 Mexiletine Mexitil® unlicensed special

Initiation under the direction of cardiologist for VT

unlicensed unlicensed: Mexiletine 50mg, 100mg and 200mg capsules are unlicesed and only available from 'special-order' manufacturers or specialist importing companies.  For treatment of life-threatening ventricular arrhythmias (using the unlicensed preperations ONLY)

 

10.02.02 Mexiletine 167mg Namuscla®

Reserved for non-dystrophic myotonia and it is not licenced for ventricular arrhythmia.

This is an NHS England specialised commissioning medicine

19.01 Mextra Super 

Use

For use on moderately to highly exuding wounds such as leg ulcers and pressure ulcers

Application

Can be used as primary or secondary dressing 

Tips 

Can be used under compression bandaging

Avoid

Do not cut

 

05.02.04 Micafungin Mycamine®
07.02.02 Miconazole Gyno-Daktarin®
13.10.02 Miconazole 

Self Care Self Care Medicine: Fungal skin infections from 1 year - 2% cream

12.03.02 Miconazole oral gel 

Self Care Self Care Medicine: Oral thrush from 4 months

04.08.02 Midazolam 
04.08.02 Midazolam Buccolam®
15.01.04.01 Midazolam 
02.07.02 Midodrine 

2.5mg and 5mg tablets

08.02.04 Mifamurtide Mepact®
07.01.02 Mifepristone 
09.08.01 Migalastat Galafold®

SaTH is not a specialist centre

This drug is NHSE funded for the indication outlined withn the Ex-Tariff list.

SPECIALIST CENTRE ONLY.

09.08.01 Miglustat Zavesca®

SaTH is not a specialist centre

This drug is NHSE funded for the indication outlined withn the Ex-Tariff list.

SPECIALIST CENTRE ONLY.

02.01.02 Milrinone Primacor®
02.05.01 Minoxidil 
07.04.02 Mirabegron Betmiga®
04.03.04 Mirtazapine 
07.01.01 Misoprostol 
08.01.02 Mitomycin 

NHSE funded through routine commissioning for chemotherapy regimes

08.01.02 Mitoxantrone (Mitozantrone) Onkotrone®

NHSE funded through routine commissioning for chemotherapy regimes

15.01.05 Mivacurium 
04.03.02 Moclobemide 
A2.03.02 Modulen IBD 
12.02.01 Mometasone Furoate 

Self Care Self Care Medicine: Seasonal allergic rhinitis (hayfever) from 18 years

13.04 Mometasone Furoate 0.1% Elocon®
03.03.02 Montelukast 
04.07.02 Morphine 

All patients receiving opioid doses of >50 mg/day morphine equivalent should be reviewed regularly (at least annually) to detect emerging harms and consider ongoing effectiveness. Pain specialist advice or review should be sought at doses >90 mg/day morphine equivalent.

02.06.04 Moxisylyte Opilon®
02.05.02 Moxonidine 
09.06.07 Multivitamin  
09.06.07 Multivitamin preparations Abidec®Dalivit®

For paediatric use only

12.02.03 Mupirocin 2% Bactroban Nasal®
13.10.01.01 Mupirocin 2% Bactroban®
08.02.01 Mycophenolate Mofetil 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

 

08.02.01 Mycophenolic acid Myfortic®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

19.24 N-A Ultra 

Use

Apply directly to wound bed.
May be used beneath multi-layer compression on leg ulcers, burns, traumatic epithelialising and granulating wounds.

Application

Will require secondary dressing and/or padding

Tips

If adherent, may be loosened with warmed saline solution. Contains silicone.

Avoid

Avoid using on patients with known silicone allergy.

 

02.06.04 Naftidrofuryl 

Patients taking naftidrofuryl should be assessed for improvement after 3-6 months

01.06.06 Naloxegol 

To be used in accordance with NICE guidelines

NICE TA345 Naloxegol for treating opioid induced constipation

15.01.07 Naloxone 
04.10.03 Naltrexone 
10.01.01 Naproxen 
08.02.04 Natalizumab Tysabri®

This drug is NHSE funded for the indictaions outlined within the Ex-Tariff list (Blueteq Drug)

08.01.03 Nelarabine Atriance®

This drug is funded by the CDF for the indications oulined with the CDF list (Blueteq Drug).

A2.03.01 Neocate Junior 
A2.03.01 Neocate LCP 
A2.03.01 Neocate Spoon 
05.01.04 Neomycin Sulphate 
12.01.01 Neomycin Sulphate with Hydrocortisone and Polymyxin Otosporin®
10.02.01 Neostigmine 
15.01.06 Neostigmine 
A2.03.02 Nepro HP 

Requires specialist (renal) dietician input

08.01.05 Neratinib Nerlynx ®

This drug is NHSE funded for the indications outlined within the NICE guidance (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model.

04.06 Netupitant and Palonosetron Akynzeo®
02.06.02 Nicardipine 
02.06.03 Nicorandil 
02.12 Nicotinic Acid 

To be initiated by a Consultant Clinical Pathologist ONLY

02.06.02 Nifedipine 

DAILY dosing - 1st line: NIDEF SR tablets 
                      2nd line: CORACTEN XL capsules

BD dosing - 1st line: ADIPINE MR tablets
                  2nd line CORACTEN SR capsules

08.01.05 Nilotinib Tasigna®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq Drug)

 

02.06.02 Nimodipine 
03.11 Nintedanib Ofev®
03.11 Nintedanib Vargatef®
08.02.04 Niraparib Zejula®

This drug is funded by the CDF for the indications outlined within the CDF list (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model

05.01.13 Nitrofurantoin 
15.01.02 Nitrous oxide 
08.02.04 Nivolumab Opdivo®

This drug is funded by NHSE for the indications within the Ex-Tariff list (Blueteq Drug)

This drug is funded by the CDF for the indications outlined within the CDF list (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model

02.07.02 Noradrenaline / Norepinephrine 
06.04.01.02 Norethisterone 
05.01.12 Norfloxacin 

Microbiology recommendation only

14.05.01 Normal immunoglobulin for Intravenous use 

This drug is NHSE funded for the indication outlined withIn the Ex-Tariff list and in accordance with the Immunoglobulin demand management plan.

Suitable for shared care between Specialist and Secondary Care via network model. 

Must complete an Immunoglobulin referral form

Must be added to Immunoglobulin Database

General Rule for supply:

RSH use Intratect® 

PRH use Privigen® 

Both sites can use Octagam® (patient specific)

 

06.01.01.02 NovoMix® 30 
06.01.01.01 NovoRapid® 
A2.05.02 Nutilis Clear 
A2.02.02.03 Nutilis Complete Stage 1 
A2.02.02.02 Nutilis Fruit 
A2.03.01 Nutramigen 1 with LGG 
A2.03.01 Nutramigen 2 with LGG 
A2.03.01 Nutramigen Puramino 
A2.01.03.01 Nutrini Low Energy Multifibre 
A2.01.03.01 Nutriprem 2  
12.03.02 Nystatin oral suspension 
01.09.01 Obeticholic acid Ocaliva®

Specialist centre only: NB - SaTH is not a specialist centre

08.02.03 Obinutuzumab Gazyvaro ®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug).

This drug is funded by the CDF for the indication outlined within the CDF list (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model

11.08.02 Ocriplasmin Jetrea®
19.14 Octenilin wound irrigation 
08.03.04.03 Octreotide Sandostatin®
08.03.04.03 Octreotide Sandostatin Lar®
06.04.01.01 Oestrogen only HRT (transdermal patch) Evorel®
06.04.01.01 Oestrogens for HRT Elleste Solo®
06.04.01.01 Oestrogens for HRT Premarin®
07.02.01 Oestrogens, Topical Oestrogel®
06.04.01.01 Oestrogens, Topical (Oestrogel®) 
05.01.12 Ofloxacin 
11.03.01 Ofloxacin Eye drops 

1st line Quinolone

04.02.01 Olanzapine 
04.02.03 Olanzapine mania, hypomania and maintenance
08.02.04 Olaparib Lynparza®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list.

This drug is funded by the CDF for the indications outlined within the CDF list (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model

 

11.04.02 Olopatadine 
01.05 Olsalazine 

Brand as indicated by specialist

03.04.02 Omalizumab Xolair®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug).

This must be initiated by a SPECIALIST centre. SaTH are not a specialist centre but can continue prescribing of this following the network model.

01.03.05 Omeprazole 

Self Care Self Care Medicine: Heartburn/Indigestion in adults for up to 2 weeks

01.03.05 Omeprazole IV 
04.06 Ondansetron 
04.09.01 Opicapone 
09.02.01.02 Oral Rehydration Salts 

Self Care Self Care Medicine: Dioralte relief - Acute diarrhoea from 1 year

Medical supervision is recommended for use during pregnancy and lactation and in infants below the age of 24 months.

04.05.01 Orlistat 
05.03.04 Oseltamivir Tamiflu®

In England, antiviral medicines may be prescribed at any time in the secondary care setting for patients with suspected seasonal influenza infection. However, general practitioners in England may only prescribe these medicines under the General Medical Services regulations when the Chief Medical Officer has announced that influenza is circulating within the community

08.02.04 Osimertinib Tagrisso

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq Drug).

This drug is funded by the CDF for the indications outlined within the CDF list (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model

A2.01.01.01 Osmolite 
A2.01.02.01 Osmolite 1.5 kcal 
A2.01.02.02 Osmolite Plus 
08.01.05 Oxaliplatin 

NHSE funded through routine commissioning for chemotherapy regimes

04.08.01 Oxcarbazepine Trileptal®
11.07 Oxybuprocaine (benoxinate) Minims®
07.04.02 Oxybutynin Immediate Release

Do not use for frail older women or aged >75 years

07.04.02 Oxybutynin Hydrochloride transdermal patch Kentera®

Apply patch twice weekly
Each patch contains 36 mg of oxybutynin, delivering 3.9mg over 24 hours

If oxybutynin or tolterodine is ineffective or not tolerated.

04.07.02 Oxycodone 

All patients receiving opioid doses of >50 mg/day morphine equivalent should be reviewed regularly (at least annually) to detect emerging harms and consider ongoing effectiveness. Pain specialist advice or review should be sought at doses >90 mg/day morphine equivalent.

Brand Choices:-

TWCCG - Shortec Capsules, Longtec MR tablets

05.01.03 Oxytetracycline 
07.01.01 Oxytocin 
08.01.05 Paclitaxel 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug)

A2.01.03.04 Paediasure Plus 
A2.02.01.02 Paediasure Plus Juce 
08.03.04.01 Palbociclib Ibrance®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list

04.02.02 Paliperidone prolonged-release suspension for injection
05.03.05 Palivizumab Synagis®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

01.09.04 Pancreatin 

Brand as indicated by specialist

15.01.05 Pancuronium 
08.01.05 Panitumumab Vectibix®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq Drug).

Suitable for shared care between specialist and secondary care via network model.

08.01.05 Panobinostat Farydak®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list.

01.03.05 Pantoprazole 

Self Care Self Care Medicine: Heartburn/Indigestion in adults for up to 2 weeks

04.07.01 Paracetamol 500mg 

Self Care Self Care Medicine:
For the relief of headache, tension headache, migraine, backache, rheumatic & muscular pain, tootheache, period pain, sore throat, fever and aches & pains of cold and flu from 12 years

04.07.01 Paracetamol and dihydrocodeine Co-dydramol 10/500
04.07.01 Paracetamol oral suspension 120mg/5ml

Self Care Self Care Medicine:
For many conditions including: Fever, teething, headache, cold & flu, tootheache, earache, sorethroat and other aches & pains from 3 months to 6 years.

04.07.01 Paracetamol suspension 250mg/5ml

Self Care Self Care Medicine:
For many conditions including: Headache, cold & flu, toothache, earache, sore throat, post-immunisation fever and other aches & pains from 6 to 12 years

09.06.07 Paravit CF Capsules and Liquid

PIL Capsules
PIL Liquid

09.03 Parenteral Nutrition TPN or PN
04.03.03 Paroxetine 
09.02.01.01 Patiromer Sorbitex Calcium Veltassa®
08.01.05 Pazopanib Votrient®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list.

09.03 Peditrace® 
08.01 Pegaspargase Oncaspar®

This drug is NHSE funded for the indication oulined in the Ex-Tariff list.

08.02.04 Peginterferon Alfa ViraferonPeg®

This drug is NHSE funded for the indication oulined in the Ex-Tariff list.

08.02.04 Peginterferon Alfa Pegasys®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

08.02.04 Peginterferon Alfa PegIntron®

This drug is NHSE funded for the indication oulined in the Ex-Tariff list.

08.02.04 Peginterferon Beta-1a Plegridy®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list 

08.01.05 Pembrolizumab Keytruda®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug)

This drug is funded by the CDF for the indication outlined within the CDF list (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model.

Please note that Pembrolizumab for drug-resistant gestational trophoblastic neoplasia (170027P) is for specialist centre use only. As according to commissioning policy 170027P

08.02.04 Pembrolizumab Keytruda®

This drug is NHSE funded for the indications outllined within the Ex-Tariff list (Blueteq Drug)

This drug is funded by the CDF for the indication outlined within the CDF list (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model

Please note that Pembrolizumab for drug-resistant gestational trophoblastic neoplasia (170027P) is for specialist centre use only. As according to commissioning policy 170027P

08.01.03 Pemetrexed Alimta®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug).

This drug is funded by the CDF for the indications outlined within the CDF list.

Suitable for shared care between specialist and secondary care via network model.

09.08.01 Penicillamine 
10.01.03 Penicillamine 
05.04.08 Pentamidine Isetionate Pantacarinat®

On recommendation by microbiology only.

07.04.02 Pentosan polysulfate Elmiron®

NICE TA610 Pentosan polysulfate sodium for treating bladder pain syndrome

08.01.05 Pentostatin Nipent®
02.06.04 Pentoxifylline 
01.02 Peppermint Oil Mintec®
01.02 Peppermint water 
01.01.02 Peptac ® 

Self Care Self Care Medicine: Heartburn/Indigestion from 6 yrs

A2.01.01.01 Peptamen 
04.08.01 Perampanel 

This medication requires an ESCA

A2.01.02.02 Perative 
04.09.01 Pergolide 
02.05.05.01 Perindopril erbumine or tert-butylamine 
13.10.04 Permethrin 5% Lyclear® Dermal Cream
08.01.05 Pertuzumab Perjeta®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq Drug)

This drug is funded by the CDF for the indications oulined within the CDF list (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model

04.07.02 Pethidine 
04.03.02 Phenelzine 
02.08.02 Phenindione 
04.08.01 Phenobarbital 
04.08.02 Phenobarbital injection 
02.05.04 Phenoxybenzamine Hydrochloride 
05.01.01.01 Phenoxymethylpenicillin 
11.05 Phenylephrine Hydrochloride 
04.08.01 Phenytoin 
04.08.02 Phenytoin 
09.05.02.01 Phosphate Polyfusor ® 
09.05.02.01 Phosphate supplements Phosphate-Sandoz®
01.06.04 Phosphates (Rectal) 
09.06.06 Phytomenadione 
11.06.05 Pilocarpine 

For the following indication only: Pseudoexfoliation Glaucoma

13.05.03 Pimecrolimus 

Not recommended as first line treatment for atopic eczema of any severity

06.01.02.03 Pioglitazone Actos®
05.01.01.04 Piperacillin and Tazobactam Tazocin
03.11 pirfenidone Esbriet®
05.01.01.05 Pivmecillinam Selexid®
08.01.02 Pixantrone Pixuvri®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

04.07.04.02 Pizotifen 
A2.06.02 PK Foods Aminex low-protein 
A2.06.02 PK Foods Aminex low-protein 
A2.06.02 PK Foods low-protein 
14.04 Pneumococcal polysaccharide conjugate vaccine (adsorbed) Prevenar 13®

order via IMMFORM WEBSITE

PGD - see chapter link above

08.01.05 Polatuzumab vedotin Polivy®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq Drug).

Suitable for shared care between specialist and secondary care via network model

13.10.01.01 Polyfax ® 
11.03.01 Polymyxin B Sulphate eye ointment 
14.04 Polysaccharide Typhoid Vaccine Typherix, Typhim Vi
11.08.01 Polyvinyl Alchohol 1.4% 

1st choice - Sno Tears
2nd choice - Liquifilm Tears

Self Care Self Care Medicine:
Mild to moderate dry eye or sore tired eyes
Exceptions & OTC restrictions:
Pre-existing long-term conditions affecting the eyes
Pregnancy & breastfeeding

08.02.04 Pomalidomide Imnovid®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq Drug)

This drug is funded by the CDF for ithe indications outlined within the CDf list (Blueteq Drug)

08.01.05 Ponatinib Iclusig®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model.

06.01.01.01 Pork Actrapid® 
05.02 Posaconazole (IV) Noxafil®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

Suitable for shared care between Specialist and Secondary care via network model.

05.02 Posaconazole (oral) Noxafil®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

Suitable for shared care between Specialist and Secondary care via network model.

11.99.99.99 Potassium Ascorbate (Ascorbic acid) 
09.02.02.01 Potassium Chloride 20mmol in 20ml Water For Injection 
09.02.02.01 Potassium Chloride and Glucose Intravenous Infusion  
09.02.02.01 Potassium Chloride and Sodium Chloride Intravenous Infusion 
09.02.02.01 Potassium Chloride Concentrate (Sterile) 
09.02.01.01 Potassium Chloride Effervescent Sando-K®
09.02.01.01 Potassium Chloride syrup 75mg/ml
09.02.02.01 Potassium Chloride, Sodium Chloride and Glucose Intravenous Infusion 
06.02.02 Potassium Iodate 
19.03 Povidone Iodine 10% USP Non-adherent dressing Povitulle

Use

Wound contact layer for use on superficial infected /critically colonised wounds.
Low to moderately exuding wounds as rapidly de-activated by wound exudate.
Effective against gram-positive and gram-negative organisms, anaerobes, fungi and viruses.
Systemic antibiotics will also be needed in confirmed cases of infection.

Application

Apply directly onto wound.
Requires a secondary dressing.
Change dressing when orange colour changes to white. Maximum 4 large dressings on body at one time.
If use is continued after 2 weeks please discuss with Tissue Viability Service.

Avoid

Sensitivity to Iodine
Use in pregnant or breast feeding women as absorption of iodine can occur.
Patients with severely impaired renal function or history of any thyroid disorder as they are more susceptible to alterations in thyroid metabolism. Consult a specialist if iodine dressing used on extensive areas for more than 2 weeks or if Chronic Kidney Disease grade 4 or 5 or patient is taking lithium.
Cases of Duhring’s herpetiform dermatitis.
Use under medical supervision with infants up to 6 months old.
Do not use with hydrogels.
Data sheet available on www.medicines.org.uk

 

11.03.01 Povidone iodine 5% 
04.09.01 Pramipexole 
02.09 Prasugrel 
02.12 Pravastatin  
02.05.04 Prazosin 
01.05.02 Prednisolone 
06.03.02 Prednisolone 
08.02.02 Prednisolone 

NHSE agreement to fund prednisolone as part of post-transplant treatment alongside immunosuppressants.

11.04.01 Prednisolone 0.5% eye drops
12.01.01 Prednisolone 0.5% Predsol®
11.04.01 Prednisolone 0.5% with Neomycin 0.5% 
11.04.01 Prednisolone 1% 
11.04.01 Prednisolone preservative free eye drops 

Preservative free products are an option if the patient:
1. Has a preservative allergy 
2. Has significant external eye disease
3. Wears soft contact lenses

04.02.03 Pregabalin 

Only if all SSRIs or SNRIs are not tolerated
Be aware of the risk of misuse and dependence

04.07.03 Pregabalin 
04.08.01 Pregabalin 
15.02 Prilocaine Hydrochloride 
15.02 Prilocaine Hydrochloride with Felypressin >
05.04.01 Primaquine 

Malaria should always be managed in consultation with someone experienced in managing the disease. Advice can be sought from the on-call infectious disease SpR at Birmingham Heartlands Hospital (via switchboard). 

04.09.03 Primidone 
15.02 Procaine Hydrochloride 
A2.04.01.02 Pro-Cal 
A2.04.01.02 Pro-Cal Shot 
08.01.05 Procarbazine 

NHSE funded through routine commissioning for chemotherapy regimes

04.06 Prochlorperazine 
04.06 Prochlorperazine Buccastem® (Bucal preparation)
04.09.02 Procyclidine 
06.04.01.02 Progesterone Crinone®
06.04.01.02 Progesterone Cyclogest®

For Fertility Use Only

04.02.01 Promazine Hydrochloride 
04.06 Promethazine Hydrochloride Phenergan

Self Care Self Care Medicine - Travel sickness from age 2

04.01.01 Promethazine Hydrochloride 
A2.06.02 Promin low-protein 
A2.06.02 Promin low-protein 
A2.06.02 Promin low-protein 
A2.06.02 Promin low-protein 
02.03.02 Propafenone 
13.12 Propantheline Pro-Banthine®
  • For hyperhidrosis (licensed indication)
  • Specialist recommendation
15.01.01 Propofol 
02.04 Propranolol 

Anxiety, Migraine, Tremor or Thyrotoxicosis

04.07.04.02 Propranolol 
04.09.03 Propranolol 
06.02.02 Propylthiouracil 
A2.04.01.03 ProSource Jelly 
A2.04.01.03 ProSource Liquid 
A2.04.01.03 ProSource Plus 
A2.04.01.03 ProSource TF 
02.08.03 Protamine Sulphate 
18 Protamine Sulphate 
02.11 Protein C Concentrate 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

11.07 Proxymetacaine Minims®
01.06.07 Prucalopride 
05.01.09 Pyrazinamide 
05.01.09 Pyrazinamide  

Where appropriate doses should be rounded up/down to facilitate the use of the licenced tablets

10.02.01 Pyridostigmine Bromide 
09.06.02 Pyridoxine Hydrochloride 
14.04 Quadrivalent Influenza Vaccine  Split Virion, inactivated

PGD - see chapter link above

04.02.01 Quetiapine 

XL - Brand choices:
TWCCG - Sondate XL
SCCG - Sondate XL or Brancico XL

04.02.03 Quetiapine immediate release mania, hypomania and maintenance
05.04.01 Quinine 

Malaria should always be managed in consultation with someone experienced in managing the disease. Advice can be sought from the on-call infectious disease SpR at Birmingham Heartlands Hospital (via switchboard). 

10.02.02 Quinine 
14.04 Rabies vaccine 

Travel vaccines provided as a private service.

Bat handlers who regularly handle bats, are entitled to free pre-exposure vaccine on the NHS - this can be ordered by the GP from Public Health England.
For other groups, the vaccine is not available on the NHS and should be obtained through their employer's occupational health department.

 

06.04.01.01 Raloxifene Hydrochloride Evista®
02.05.05.01 Ramipril 
08.01.05 Ramucirumab Cyramza®

This drug is NHSE funded for the indication outlined in the Ex-Tariff list at specialised centres only.

An IFR is needed if using outdside of commisoning policy.

11.08.02 Ranibizumab 
01.03.01 Ranitidine 

Self Care Self Care Medicine: Heartburn/Indigestion from 16 yrs

02.06.03 Ranolazine 
04.09.01 Rasagiline 
10.01.04 Rasburicase 
08.01.05 Regorafenib Stivarga®

This is NHSE funded for the indications outlined within the Ex-Tariff list.

15.01.04.03 Remifentanil 
14.04 Repevax ® 

Order via IMMFORM WEBSITE

PGD - see chapter link above

14.04 Revaxis ® 

order via IMMFORM WEBSITE

PGD - see chapter link above

05.03.05 Ribavirin 
08.01.05 Ribociclib Kisqali®

Ths drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug).

This drug is funded by the CDF for the indication outlined within theCDF list (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model.

05.01.09 Rifabutin 
05.01.09 Rifampicin 
05.01.09 Rifampicin and Isoniazid 
05.01.09 Rifampicin and Isoniazid and Pyrazinamide 
05.01.09 Rifampicin, isoniazid, pyrazinamide and ethambutol 
05.01.07 Rifaximin 
04.09.03 Riluzole Rilutek®
13.05.03 Risankizumab Dermatology
06.06.02 Risedronate  
06.06.02 Risedronate 

For Osteoporosis

04.02.01 Risperidone 
04.02.02 Risperidone prolonged-release suspension for injection
04.02.03 Risperidone mania and hypomania
08.02.03 Rituximab Truxima®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list. To reveiw the policies, click the specific indications below:

Steroid sensitive AND resistant nephrotic syndrome & Juvenile arthritis 

Primary sjogren's syndrome

Chronic inflammatory demyelinating polyneuropathy

Acquired haemophilia

ANCA-positive vasculitis & SLE

Anti-NMDAR autoimmune encephalitis & Dermatomyositis optica

Cytopenia complicating primary immunodeficiency

Cytopaenia complicating primary immunodeficiency

Dermatomyositis and polymyositis (Adults)

Pemphigus vulgaris and pemphigoid disease

Immunoglobulin G4 related disease

Myasthenia gravis

The following have individual policies but will need an IFR if used outside of the criteria indicated within its policy: Connective tissue disease/Interstitial lung disease, Membranous nephropathy, Focal segmental glomerulosclerosis, Delayed haemolytic transfusion reactions and hyperhaemolysis in

 

08.02.03 Rituximab MabThera®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list

 

10.01.03 Rituximab (rheumatology) 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list. as per the NHSE commissioning policy Juvenile Arthritis-Paediatric

Blueteq form required (Blueteq Drug).

Suitible for shared care

NHSE commission Rituximab for refractory Systemic Lupus Erythematosus (SLE) in adults and post-pubescent children according to NHSE Clinical Commissioning Policy Reference 200402P

SaTH are not a specialist for SLE

02.08.02 Rivaroxaban 
04.11 Rivastigmine 
15.01.05 Rocuronium 
03.03.03 Roflumilast Daxas®
09.01.04 Romiplostim 
04.09.01 Ropinirole 

Brand Choice:-

TWCCG - MR product -  Repinex XL (branded generic)

15.02 Ropivacaine Hydrochloride 
02.12 Rosuvastatin 
14.04 Rotavirus vaccine Rotarix®

Order via IMMFORM WEBSITE

PGD - see chapter link above

 

04.09.01 Rotigotine 
08.01.05 Rucaparib Rubraca ®

This drug is CDF funded for the indications outlined within the Ex-Tariff list (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model.

08.01.05 Ruxolitinib Jakavi®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

Suitable for shared care between specialist and secondary care via network model.

A2.03.02 S.O.S. S.O.S. 10, S.O.S. 15, S.O.S. 20
02.05.05.02 Sacubitril valsartan Entresto®

Started for heart failure with reduced ejection fracture under specialist supervision added once 'standard of care' optimised

Click here for Link to PID

06.01.06 Safety lancets GlucoRx®

Safety lancet devices CAN be prescribed on FP10 for use by people who are not healthcare professionals and are not employees in the healthcare sector if there is a risk of disease transmission

 

04.09.01 Safinamide 
03.01.01.01 Salbutamol nebules
07.01.03 Salbutamol 
03.01.01.01 Salbutamol 100 micrograms 
03.01.01.01 Salbutamol IV 
10.01.03 Sarilumab 
06.01.02.03 Saxagliptin 
19.22 Scanpor 
10.01.03 Secukinumab Rheumatology
13.05.03 Secukinumab 
04.09.01 Selegiline Hydrochloride 
06.01.02.03 Semaglutide Rybelsus®

SECOND LINE OPTION

Due to the lack of available cardiovascular outcome trial data for oral semaglutide this should only be considered as a second line option for patients suitable for a GLP-1 where the subcutaneous route of administration is not tolerated or advisable.

  • For the treatment of adults with insufficiently controlled type 2 diabetes mellitus (T2DM) as an adjunct to diet and exercise in addition to oral anti-diabetic medicines
  • or as an add-on to basal insulin Amber.
  • Not recommended for use as monotherapy when metformin is considered inappropriate due to intolerance or contraindications.

Due to the current lack of CV outcome superiority data and the high pharmacokinetic variability of the oral preparation, switching existing GLP-1 analogue users to oral semaglutide is not recommended.

 

 

06.01.02.03 Semaglutide 
  • For the treatment of adults with insufficiently controlled type 2 diabetes mellitus (T2DM) as an adjunct to diet and exercise in addition to oral anti-diabetic medicines
  • or as an add-on to basal insulin Amber.
  • Not recommended for use as monotherapy when metformin is considered inappropriate due to intolerance or contraindications.
01.06.02 Senna 

Self Care Self Care Medicine: Recommended for use only in people aged 18 years or older. Should no longer be used in children under 12 years without advice from a prescriber, while products for children aged 12 to 17 years can be supplied under the supervision of a pharmacist.

04.03.03 Sertraline 
09.05.02.02 Sevelamer Carbonate Renvela®

Restricted Item For patients with chewing/swallowing difficulties

09.05.02.02 Sevelamer Hydrochloride  
15.01.02 Sevoflurane 
02.05.01 Sildenafil 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

07.04.05 Sildenafil 

CCG policy limits treatment to 4 tablets per month

13.07 Silver Nitrate 40% pencil with potassium nitrate 60% AVOCA®
13.07 Silver Nitrate 95% with Potassium Nitrate 5% AVOCA®
13.10.01.01 Silver Sulfadiazine 
01.01.01 Simeticone 

Self Care Self Care Medicine: Infant colic

A2.03.01 Similac Alimentum 
02.12 Simvastatin 
08.02.02 Sirolimus Rapamune®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

Suitable for shared care between Specialist and Secondary Care via network model. 

06.01.02.03 Sitagliptin 
A2.03.01 SMA Alfamino 
A2.03.01 SMA Althera 
09.02.01.03 Sodium Bicarbonate 
09.02.02.01 Sodium Bicarbonate 
09.02.01.02 Sodium Chloride Slow Sodium®
12.02.02 Sodium Chloride 0.9% nasal drops

Self Care Self Care Medicine: Common cold/nasal congestion from 3 months

03.01.05 Sodium Chloride 0.9% nebuliser
11.08.01 Sodium Chloride 0.9% Single use drops
19.14 Sodium Chloride 0.9% irrigation solution - sterile Irripod 25 x 20ml

Use

 

To irrigate wounds that requires a sterile technique.

Application

 

Remove twist off seal then use Irripod to direct the flow of saline over the wound.

Tips

 

Use gauze to soak up irrigation waste.
Product should be warmed to body temperature before use.

 

19.14 Sodium Chloride 0.9% irrigation solution - sterile Clinipod or Steripod 25 x 20ml

Temporary replacement when Irripods unavaiable

19.14 Sodium chloride 0.9% irrigation solution - sterile Normasol 25 x 25ml

Temporary replacement when Irripods unavaialbe

03.07 Sodium chloride 3% (Hypertonic) 
11.99.99.99 Sodium Chloride 5% eye drops 
03.07 Sodium chloride 6% (hypertonic) MucoClear®

ONLY USED WHEN 7% NEBULES ARE UNAVAILABLE DUE TO MANUFACTURING PROBLEMS

03.07 Sodium chloride 7% (Hypertonic) 
09.02.02.01 Sodium Chloride and Glucose Intravenous Infusion 
09.02.02.01 Sodium Chloride Intravenous 
01.06.04 Sodium Citrate 
01.01.02 Sodium citrate 0.3M 
06.06.02 Sodium Clodronate 
03.03.01 Sodium Cromoglicate 
11.04.02 Sodium Cromoglicate 

Self Care Self Care Medicine: Mild to meoderate hayfever from 6 years

09.01.01.01 Sodium Feredetate Sytron®
11.08.01 Sodium Hyaluronate 0.2% Hylo-Forte®

Self Care Self Care Medicine: Mild to moderate dry eye or sore tired eyes
Exceptions & OTC restrictions:
Pre-existing long-term conditions affecting the eyes
Pregnancy & breastfeeding

02.05.01 Sodium nitroprusside 

For hypertensive crisis only

01.06.02 Sodium Picosulfate 
04.08.01 Sodium Valproate Epilim® Chrono
04.08.01 Sodium Valproate Epilim® Intravenous
04.08.01 Sodium Valproate 
09.02.01.01 Sodium Zirconium Cyclosilicate Lokelma®
05.03.03.02 Sofosbuvir Sovaldi®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

Prescribed as part of the Run Rate Card and through the hub-spoke model.

05.03.03.02 Sofosbuvir and Velpatasvir Epclusa®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

Prescribed as part of the Run Rate Card and through the hub-spoke model.

07.04.02 Solifenacin 

If oxybutynin or tolterodine is ineffective or not tolerated.

09.03 Solivito N® 
06.05.01 Somatropin 
06.05.01 Somatropin Growth Hormone for ADULTS

 

Shropshire CCG ESCA is currently under review

08.01.05 Sorafenib Nexavar®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug).

 

This drug is funded by the CDF for the indication outlined within the CDF list.

02.04 Sotalol 

Initiated by hospital specialist only

02.02.03 Spironolactone 
19.08 Sterile dressing pack Dressit

 

Sterile Pack containing:  
    1 Pair Vitrex Gloves small/medium, medium/large  
    1 Large Apron    
    1 Disposable Bag 26cm x 46cm  
    1 Paper Towel 45cm x 50cm  
    4 Softswabs 4 ply 10cm x 10cm  
    1 Absorbent Pad 10cm x 12cm  
    1 Sterile field 50cm x 50cm  

 

Use

To aid wound care process that requires a sterile technique

Tips

Use for aseptic dressing technique
Available is glove sizes; small, medium and large

 

13.11.07 Sterile Larvae (Maggots) LarvE®

Must ONLY be prescribed on recommendation of Tissue Viability

02.10.02 Streptokinase 
01.03.03 Sucralfate 
09.05.02.02 sucroferric oxyhydroxide Velphoro®
15.01.06 Sugammadex 
01.05 Sulfasalazine 

Brand as indicated by specialist

 

 

10.01.03 Sulfasalazine EC 
10.01.04 Sulfinpyrazone 
04.02.01 Sulpiride 
04.07.04.01 Sumatriptan 
08.01.05 Sunitinib Sutent®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq Drug).

13.08.01 Sunsense ® Ultra SPF 50

ACBS indication only : Photodermatoses

09.01.05 Susoctocog alfa Obizur®
15.01.05 Suxamethonium Chloride 
08.02.02 Tacrolimus Prograf ®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

Suitable for shared care between Specialist and Secondary Care via network model. 

08.02.02 Tacrolimus 

This drug is NHSE funded for the indications outlined within the Ex-Tariff list.

Suitable for shared care between Specialist and Secondary Care via network model.

08.02.02 Tacrolimus Modigraf ®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

Suitable for shared care between Specialist and Secondary Care via network model. 

08.02.02 Tacrolimus Advagraf ®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

Suitable for shared care between Specialist and Secondary Care via network model. 

08.02.02 Tacrolimus  AdoPORT ®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

Suitable for shared care between Specialist and Secondary Care via network model. 

13.05.03 Tacrolimus 

Not recommended for first line treatment of atopic eczema of any severity

02.05.01 Tadalafil 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

07.04.05 Tadalafil 

CCG policy limits treatment to 4 tablets per month

08.02.04 Talimogene laherparepvac Imlygic®

This drug is NHSE funded for the indication outlined in the Ex-Tariff list

08.01.05 Talimogene laherparepvec Imlygic®

This drugs is NHSE funded for the indication oulined within the Ex-Tariff list (Blueteq Drug).

08.03.04.01 Tamoxifen 
07.04.01 Tamsulosin modified release Pamsvax®
A2.06.02 Taranis low-protein 
A2.06.02 Taranis low-protein 
01.04.02 Teduglutide 

This drug is NHSE funded through the individual funding request process for the indications outlined within the Ex-Tariff list.

05.01.07 Teicoplanin 

 

MRSA: Outpatient therapy may be required in some cases

04.01.01 Temazepam 
15.01.04.01 Temazepam 
06.07 Temozolomide 

This drug is NHSE funded for the indications outlined within the Ex-Tariff list.

08.01.05 Temozolomide Temodal®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list 

05.03.03.01 Tenofovir Disproxil 
05.02 Terbinafine 
13.10.02 Terbinafine 1% cream 

Self Care Self Care Medicine: Fungal skin infections from 16 years

03.01.01.01 Terbutaline nebules
07.01.03 Terbutaline 
03.01.01.01 Terbutaline turbohaler 
08.02.04 Teriflunomide Aubagio®

Ths drug is NHSE funded for the indication outlined within the Ex-Tariff list  (Blueteq Drug).

06.06.01 Teriparatide 

 - Male and Paediatric patients
NHSE - Women

06.05.02 Terlipressin 
06.01.06 Test strips Aviva®

Restricted use with pump meters only  - Initiated by specialist only. Patients will require access to a first line ketone meter see above

06.01.06 Test strips TEE2®
06.01.06 Test strips WaveSense Jazz ®
06.01.06 Test strips CareSens Pro®

Only for patients who have been issued with a CareSens Dual meter as they have been identified as requiring regular ketone testing alongside blood glucose monitoring

06.01.06 Test strips KetoSens®

Only for patients who have been issued with a CareSens Dual meter as they have been identified as requiring regular ketone testing alongside blood glucose monitoring

06.01.06 Test strips Mobile Cassette®

Only for patients who have been issued with a Accu-chek Mobile meter as practical consideration for work related requirements or dexterity problems with strip insertion have been identified (and for use in schools)

06.01.06 Test strips GlucoMen Areo®Ketone

Only for patients who have been issued with a GlucoMen Areo 2K meter as they have been identified as requiring regular ketone testing alongside blood gucose monitoring

06.01.06 Test strips Nexus®

Only for patients who have been issued with a Nexus voice meter as they have been identified as dysnumerate, dysliterate or visually impaired

06.01.06 Test strips Performa®

Only for patients who have been issued with a Accu-chek Performa Nano meter as they have been identified as having dexterity problems (also for use in schools)

06.01.06 Test strips Contour Next®

Restricted use with pump meters only - Initiated by specialist only. Patients will require access to a first line ketone meter see above.

06.01.06 Test strips FreeStyle Lite®

Restricted use with pump meters only - Initiated by specialist only. Patients will require access to a first line ketone meter see above

06.01.06 Test strips GlucoMen Aero®

Only for patients who have been issued with a GlucoMen Areo 2K meter as they have been identified as requiring regular ketone testing alongside blood glucose monitoring

06.01.06 Test strips FreeStyle Optium®

Restricted use with Flash glucose monitoring freestyle libre meters

Only for use with flash glucose funded patients

 

06.04.02 Testosterone and Esters Testim®
06.04.02 Testosterone and Esters Testogel®
06.04.02 Testosterone gel  Tostran®
06.04.02 Testosterone injection Sustanon 250®
06.04.02 Testosterone undecanoate Nebido®
14.05.02 Tetanus immunoglobulin 
11.07 Tetracaine Minims® Amethocaine
15.02 Tetracaine (Amethocaine) 
06.05.01 Tetracosactide 
05.01.03 Tetracycline 
08.02.04 Thalidomide Celgene®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list

03.01.03 Theophylline 

Brand as indicated  by specialist

09.06.02 Thiamine 
09.06.02 Thiamine Pabrinex®
15.01.01 Thiopental 
08.01.01 Thiotepa 

NHSE funded through routine commissioning for chemotherapy regimes

06.04.01.01 Tibolone Livial®
02.09 Ticagrelor 
05.01.01.04 Ticarcillin with clavulanic acid Timentin®
05.01.03 Tigecycline Tygacil®

** Micriobiology approval only **

13.05.03 Tildrakizumab Dermatology
13.04 Timodine ® 
11.06.02.01 Timolol 

Default 0.25% strength to be prescribed.

0.5% strength to be prescribed during supply/manufacturing issues.

11.06.02.02 Timolol preservative free Tiopex® eye gel

Preservative free products are an option if the patient:
1. Has a preservative allergy 
2. Has significant external eye disease
3. Wears soft contact lenses

02.08.01 Tinzaparin 
08.01.03 Tioguanine Lanvis®

NHSE funded as part of routine commissioning for chemotherapy regimes

03.01.02 Tiotropium 10microgram Braltus®

NB: Not currently supported by the COPD pathway

10.02.02 Tizanidine 
05.01.04 Tobramycin 

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

For other indications it can be prescribed in Primary Care on the recommendation of a specialist.

05.01.04 Tobramycin inhaler TOBI Podhaler®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

For other indications it can be prescribed in Primary Care on the recommendation of a specialist.

 

10.01.03 Tocilizumab 
01.05.03 Tofacitinib Gastroenterology

CCG funded as per NICE TAGs below

10.01.03 Tofacitinib citrate 
07.04.02 Tolterodine Immediate Release
07.04.02 Tolterodine MR or XL 

Preferred band = NEDITOL XL

06.05.02 Tolvaptan Jinarc®
06.05.02 Tolvaptan Samsca®

May only be prescribed by a Consultant with the agreement of an Endocrinologist - only for Cancer patients with severe or "chemotherapy delaying" SIADH hyponatraemia.

19.16 Topical negative pressure wound dressing Avelle

Negative pressure is only to be used in consultation with Tissue Viability Nurse only

04.07.04.02 Topiramate 
04.08.01 Topiramate 
08.01.05 Topotecan Hycamtin®

NHSE funded through routine commissioning for chemotherapy regimes

06.01.01.02 Toujeo® 

Restricted to second-line use after Lantus® (insulin glargine)

Solostar pen: delivers a dose of 1-80 units per single injection in steps of 1 unit

Doublestar pen: delivers a dose of 2-160 units per single injection in steps of 2 unit
Recommended for patients requiring ≥20 units/day

08.01.05 Trabectedin Yondelis®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list.

04.07.02 Tramadol 

Brand choice for MR preparation:-

TWCCG - Marol MR (branded generic)

08.01.05 Trametinib Mekinist®

This drugs is NHSE funded for the indication oulined within the Ex-Tariff list (Blueteq Drug).

Suitable for shared care between specialist and secondary care via network model.

02.11 Tranexamic Acid 
08.01.05 Trastuzumab Herceptin®

This drug is NHSE funded for the indications outlined  within the Ex-Tariff list.

08.01.05 Trastuzumab deruxtecan Enhertu®

Enhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens.

This drug is funded by the CDF for the indications oulined within the CDF list (Blueteq Drug)

08.01.05 Trastuzumab emtansine Kadcyla®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model

11.06.01.01 Travoprost 
11.06.01.03 Travoprost with Timolol DuoTrav®
08.01.01 Treosulfan 

NHSE funded through routine commissioning for chemotherapy regimes

06.01.01.02 Tresiba® Insulin degludec

Restricted to patients with type 1 diabetes who meet the prescribing criteria

06.01.01.02 Tresiba® Insulin degludec

Restricted to patinets with type 1 diabetes who meet the prescribing criteria

08.01.05 Tretinoin Vesanoid®

NHSE funded through routine commissioning for chemotherapy regimes

10.01.02 Triamcinolone Acetonide Kenalog®
06.01.01.03 TriCare 4mm, 5mm and 6mm

4mm needle are deemed to be the safest pen needle for adults and children regardless of age, gender and Body Mass Index (BMI).

For patients currently using longer pen needle lengths (8mm, 12mm), it is advisable to change to a shorter needle length (6mm or less) but only after discussion with a healthcare professional, to ensure they receive advice on the correct injection technique.

08.01.05 Trifluridine-tipiracil Lonsurf®

This drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug).

Suitable for shared care between specialist and secondary care via network model.

04.09.02 Trihexyphenidyl 
05.01.08 Trimethoprim 
05.01.13 Trimethoprim 
06.07.02 Triptorelin 
08.03.04.02 Triptorelin Gonapeptyl Depot®
08.03.04.02 Triptorelin Decapeptyl®
11.05 Tropicamide 
07.04.02 Trospium XL 

If oxybutynin or tolterodine is ineffective or not tolerated.

07.03.05 Ulipristal 30mg 
03.01.02 Umeclidinium 

NB: Not currently supported by the COPD pathway

03.01.04 Umeclidinium & vilanterol 
10.01.03 Upadacitinib 
19.06 UrgoKTwo Multi-layer compression bandage kit

Use

Compression therapy for venous ulcers and chronic oedema.

Application

Always measure above the malleoli at each application. Doppler assessment required prior to the application of compression therapy.

Tips

Apply as manufacturer’s instructions.
May be left in place for 7 days.
Ensure 50% overlap exact and no 'windows' or the pressure will be uneven.
For 18 – 25 cm, keep performance indicator at top edge of bandage. Always bandage foot and ankle with 'toes to nose'.
For reduced ABPI results K-two ‘Reduced’ compression system is available- please seek advice from Tissue Viability Team before application.

Avoid

Any form of compression bandaging should not be undertaken without prior education and competency assessment.
Arterial disease, arterial ulcers, diabetes and those with small vessel disease, with known latex allergy – seek specialist advice.
Avoid overstretching the performance indicator.

 

19.06 UrgoKTwo Latex-Free Multi-layer compression bandage kit
19.06 UrgoKTwo Reduced Multi-layer compression bandage kit
19.06 UrgoKTwo Reduced Latex-Free Multi-layer compression bangage kit
19.04 Urgotol SSD 
 

MUST be prescribed as a course of treatment
MUST be reviewed every 2-weeks
Ongoing treatment after 2-weeks MUST be discussed with a specialist

Use

Superficial, partial thickness and full thickness burns.
Pressure and leg ulcers.
Must be prescribed as a course of treatment.
Must be reviewed every two weeks.
Ongoing treatment after four weeks must be discussed with a specialist.

Application

Apply directly to wound bed.
Change dressing every 24 – 48 hours depending on wound progress.
Will require secondary dressing and/or padding.
Easier to apply with moistened gloved hands.
Unless used in palliative care settings these products must be reviewed on a regular basis, at least every month. This should ideally include discussion with a specialist.

Tips

If adherent, may be loosened with warmed saline solution.

Avoid

Sensitivity to silver and sulphonamides.
Renal/hepatic insufficiency, pregnant women and neonates.

 

02.10.02 Urokinase 
01.09.01 Ursodeoxycholic acid 
01.05.03 Ustekinumab Gastroenterology

CCG funded as per NICE TAGs below:

10.01.03 Ustekinumab rheumatology
13.05.03 Ustekinumab 
13.08.01 Uvistat ® SPF 30 and SPF 50

ACBS indication only : Photodermatoses

13.08.01 Uvistat® lipscreen SPF50

ACBS indication only : Photodermatoses

05.03.02.01 Valaciclovir Valtrex®

2nd line shingles

05.03.02.02 Valganciclovir 
04.02.03 Valproic Acid semisodium valproate
02.05.05.02 Valsartan CAPSULES

Prescribe as CAPSULES

05.01.07 Vancomycin 

Severe Clostridium Difficile

05.01.07 Vancomycin 
08.01.05 Vandetanib Caprelsa®

This drug is funded by NHSE for the indications outlined in the Ex-Tariff List. If the indciation for use lies outside this guideline an IFR is required.

04.10.02 Varenicline Champix®

Must be supported with smoking cessation counselling through smoking cessation provider

14.04 Varicella Zoster vaccine Zostavax®

Order via IMMFORM WEBSITE

PGD - see chapter link above

14.05.02 Varicella-Zoster immunoglobulin VZIG
06.05.02 Vasopressin 
15.01.05 Vecuronium 
01.05.03 Vedolizumab 
This drug is NHSE funded for the indication outlined within the Ex-Tariff list.
NHSE commissioned for Paediatric Indications (where Adult TA available)
 
 
CCG funded as per NICE TAGs below:
08.01.05 Vemurafenib Zelboraf®

This drug is NHSE funded for the indications outlined within the Ex-Tariff list.

08.01.05 Venetoclax Venclyxto®

Ths drug is NHSE funded for the indication outlined within the Ex-Tariff list (Blueteq Drug).

This drug is funded by the CDF for the indication outlined within the CDF list (Blueteq Drug)

Suitable for shared care between specialist and secondary care via network model.

04.03.04 Venlafaxine XL 
02.06.02 Verapamil 
04.08.01 Vigabatrin Sabril®
06.01.02.03 Vildagliptin 
08.01.04 Vinblastine Sulphate Velbe®

NHSE funded as part of routine commissioning for chemotherapy regimes

08.01.04 Vincristine Sulphate Oncovin®

NHSE funded as part of routine commissioning for chemotherapy regimes

08.01.04 Vinorelbine Navelbine®

NHSE funded as part of routine commissioning for chemotherapy regimes

A2.06.02 Vita Bite 
A2.01.02.01 Vital 1.5kcal 
09.06.02 Vitamin B Compound Strong tablets 

Only supported for short-term use (10 days) for patients at risk of refeeding syndrome.

Following RMOC guidance DO NOT prescribe for:
Prevention of Wernicke's Encephalopathy in alcoholism
Preventing deficiency or for maintenance treatment following treatment for deficiency

09.03 Vitlipid N® 
19.01 Vliwasorb Pro Super absorbant

Use

Secondary absorbent dressing for moderate to highly exuding wounds.

Application

Requires securing with tape, bandage or Actifast.

Avoid

Do not cut.

 

03.01.05 Volumatic ® 
09.01.05 Vonicog alfa Veyvondi®

Commissioned as part of Haemophilia Framework

The clinical criteria and agreed treatment pathway are set out in the policy which can be found at: www.england.nhs.uk/wp-content/uploads/2020/09/1709-vonicog-alfa-clinical-commissioning-policy.pdf

 

11.99.99.99 Voretigene neparvovec Luxturna

Due to the highly specialised nature of this gene therapy and low patient numbers, initially, only the following Trusts have been commissioned to provide this treatment:

  • Great Ormond Street Hospital NHS Foundation Trust jointly with Moorfields Hospital NHS Foundation Trust
  • Oxford University Hospitals NHS Foundation Trust
  • Manchester University Hospitals NHS Foundation Trust

SATH is not a specialist centre

Please refer to one of the commissioned specialist centres.

Voretigene neparvovec is an adenoassociated virus vector-based gene therapy. It introduces a healthy copy of the defective RPE65 gene into the retinal cells of people with RPE65-mediated inherited retinal dystrophy (IRD), enabling patients to produce functional RPE65 protein. The aim is to improve visual function (performance of the eyes) and functional vision (the ability to carry out activities of daily living dependent on vision).

Voretigene neparvovec is administered as a one-off subretinal injection.

Patients will be required to have had a clinical assessment and appropriate genetic testing in advance of treatment at the specialist centre. Patients will also be required to attend initial follow-up at the administering centre, with on-going routine outpatient follow-up provided locally.

NICE HST11: Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutations

05.02 Voriconazole 

Ths drug is NHSE funded for the indication outlined within the Ex-Tariff list

04.03.03 Vortioxetine 
02.08.02 Warfarin 
09.02.02.01 Water for Injection 
19.01 Xupad 
12.02.02 Xylometazoline 0.05% 

Self Care Self Care Medicine: add For the symptomatic relief of nasal congestion, perennial and allergic rhinitis (including hayfever, sinusitis) from 6-12 years

12.02.02 Xylometazoline 0.1% 

Self Care Self Care Medicine: For the symptomatic relief of nasal congestion, perennial and allergic rhinitis (including hayfever, sinusitis) from 13 years

12.02.02 Xylometazoline 0.1% nasal spray

Self Care Self Care Medicine: For the symptomatic relief of nasal congestion, perennial and allergic rhinitis (including hay fever), sinusitis from 13 years

05.03.04 Zanamivir inhalation Relenza®

In England, antiviral medicines may be prescribed at any time in the secondary care setting for patients with suspected seasonal influenza infection. However, general practitioners in England may only prescribe these medicines under the General Medical Services regulations when the Chief Medical Officer has announced that influenza is circulating within the community

05.03.04 Zanamivir Injection 
13.02.01 ZeroAQS® Cream 

For soap substitute only

Self Care Self Care Medicine: Contact dermatitis/atopic eczema/dry skin in adults and children

13.02.01 Zerobase ® Cream 

Self Care Self Care Medicine: Contact dermatitis/atopic eczema/dry skin in adults and children

19.20 Zerobase Cream 

Use

Zerobase cream contains liquid paraffin which has an emollient moisturising action on dry or chapped skin.
For the symptomatic treatment of red, inflamed, damaged, dry or chapped skin, the protection of raw skin areas and as a pre-bathing emollient for dry/eczematous skin to alleviate the effects of drying.

Application

Apply liberally in the same direction as hair growth to prevent folliculitis. Fire hazard.
Apply as a pre-bathing emollient when required.

Tips

Consider patient dexterity for pump actions.

Avoid

Avoid if sensitisation occurs (very rarely).

 

19.20 Zerocream 
13.02.01 Zerocream ® Cream 

Self Care Self Care Medicine: Contact dermatitis/atopic eczema/dry skin in adults and children

19.20 Zeroderm ointment 

Use

Zeroderm is an emollient containing liquid paraffin and white soft paraffin which has an emollient moisturising action on dry skin conditions. Can be used as a barrier to aid moisture retention in the skin and as a skin cleanser (soap substitute). It provides all the moisturising and protective benefits of paraffin based emollients. Useful in the treatment of eczema, psoriasis and all dry skin conditions.

Application

Apply liberally in the same direction as hair growth to prevent folliculitis

Tips

As this product is inflammable the patient must be advised about safe use/storage of product. Fire hazard.

Avoid

Avoid if sensitisation occurs (very rarely).

 

13.02.01 Zerodouble ® Gel  

Self Care Self Care Medicine: Contact dermatitis/atopic eczema/dry skin in adults and children

19.20 Zerodouble gel 

Use

Zerodouble emollient gel is a Sodium Lauryl Sulphate (SLS) free gel containing 30% emollient and 10% glycerol. For relief of red, inflamed, damaged, dry or chapped skin, dermatitis, ichthyosis and pruritus in elderly people.

Application

Apply liberally in the same direction as hair growth to prevent folliculitis.

Avoid

Avoid if sensitisation occurs (very rarely).

 

19.01 Zetuvit E NON-STERILE Absorbant Pad
19.01 Zetuvit E STERILE 

Use

Secondary absorbent dressing for low to moderate exuding wounds 

Application

Place on wound with blue line uppermost
Requires securing with tape, bandage or Actifast

   
 

 

 

19.15 Zinc oxide 10% bandage BP Viscopaste

Use

 

Used in association with compression for the treatment of venous leg ulcers.
For patients with high skin sensitivities due to reduced number of parabens and additives.

Application

 

Apply from toe to below knee in spiral, pleating bandage every turn at the front of the leg.

Tips

 

Patch test prior to application.
Maybe left in place for up to 7 days.
Secure with retention bandage.

Avoid

Allergy to zinc or hydroxybenzoates. Not for macerated skin.

 

09.05.04 Zinc Sulphate Solvazinc®
09.05.01.02 Zoledronic Acid IV 
04.07.04.01 Zolmitriptan 
04.01.01 Zolpidem 

Maximum daily dose of 10mg

04.08.01 Zonisamide Zonegran®
04.01.01 Zopiclone 

Maximum daily dose of 7.5mg

04.02.01 Zuclopenthixol 
04.02.02 Zuclopenthixol Decanoate 
Shropshire and Telford Local Health Economy